hg_10116.1

Basic information about the TSS

---

TSS ID: hg_10116.1 Species: human Chr: chr1		Start: 8423663 End: 8423692 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000476556.5 ENST00000492766.5 AF016005 Distance: 0 GeneID: 473 HGNC/MGI_ID: HGNC:9965 UniProt_ID: Q9P2R6

Gene_name: arginine-glutamic acid dipeptide repeats Gene_symbol: RERE Gene_synonyms: ARG ARP ATN2 DNB1 KIAA0458 Gene_source: HGNC:9965

TATA-Box annotation

---

Distance to TSS:	154
Nearest PromoterID:	NM_001042682
Entrez ID:	473
Nearest Unigene:	Hs.463041
Nearest Refseq:	NM_012102
Nearest Ensembl:	ENSG00000142599
Gene Name:	arginine-glutamic acid dipeptide repeats
Gene Alias:	ARG|ARP|ATN1L|DNB1|NEDBEH
Gene Description:	arginine-glutamic acid dipeptide repeats
Gene Type:	protein-coding
CpG%:	0.155
GC%:	0.825871
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RERE p2@RERE p3@RERE p4@RERE p5@RERE p6@RERE p7@RERE p8@RERE p9@RERE p10@RERE
Sample		p1@RERE	p2@RERE	p3@RERE	p4@RERE	p5@RERE	p6@RERE	p7@RERE	p8@RERE	p9@RERE	p10@RERE
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.84	4.87	2.73	1.17	0.58	1.56	7.01	1.75	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.22	7.08	1.01	1.42	1.01	1.82	8.09	1.82	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.94	6.17	1.93	1.35	0.77	2.31	9.65	0.96	0.58	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	20.38	6.24	1.87	1.66	0.62	1.66	5.82	1.04	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	18.45	7.87	1.12	1.35	0.22	1.80	6.97	0.67	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	14.34	6.20	1.94	1.74	0.39	2.13	6.98	1.94	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	14.38	7.19	3.92	1.74	1.31	2.83	5.45	2.40	0.44	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.05	7.75	1.45	0.73	1.45	2.91	5.57	1.21	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	18.81	10.04	0.85	1.07	0.21	2.35	5.34	1.92	0.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.34	6.96	2.32	2.90	0.58	2.32	1.74	0.58	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	24.25	10.11	4.04	1.62	0.81	1.62	3.64	3.23	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	25.61	6.10	4.07	0.41	0.81	2.44	5.69	1.22	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.58	0.81	0.97	1.77	3.22	0.48	2.58	5.32	0.64	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	5.11	0.90	2.86	1.35	2.41	0.60	1.65	3.61	0.15	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.71	1.54	0.88	1.98	2.63	0.22	1.76	3.29	0.22	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.78	0.25	0.50	1.26	1.51	0.75	1.01	4.78	0.00	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.46	1.09	2.40	1.31	1.75	0.44	1.75	1.75	0.00	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.59	1.27	2.11	1.69	3.80	0.00	1.69	4.22	0.42	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	2.13	1.07	2.13	1.60	1.07	0.00	2.13	1.07	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.21	1.20	1.50	1.50	2.26	0.45	1.96	1.81	0.15	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	5.61	1.07	1.60	1.74	2.14	0.27	2.67	2.54	0.27	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	6.21	0.86	0.86	1.21	2.59	0.86	3.11	2.07	0.35	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	6.20	0.52	1.55	1.16	1.16	0.52	2.07	3.49	0.52	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.10	0.24	2.18	1.46	3.64	0.73	2.67	2.43	0.00	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	3.87	0.77	0.52	1.03	1.03	0.52	0.52	3.10	0.00	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.01	1.27	1.90	1.58	2.22	0.63	0.63	1.90	0.95	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	1.10	1.65	2.75	3.30	0.00	3.30	1.65	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	6.37	1.18	0.47	0.94	2.36	0.71	2.83	2.36	0.47	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	3.55	0.16	0.65	0.65	2.42	0.32	3.39	2.91	0.81	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	3.44	0.72	0.36	0.72	2.17	0.54	1.99	2.90	0.18	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.65	0.21	0.63	1.26	1.88	0.42	3.77	2.72	0.42	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	2.93	0.98	1.56	0.78	3.13	0.78	1.76	1.95	0.20	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	3.80	0.63	1.48	1.48	2.95	0.42	4.01	1.69	0.21	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	2.14	0.99	0.66	0.66	1.65	0.00	3.30	1.48	0.66	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.24	1.12	0.75	0.93	2.24	0.75	3.55	0.93	0.19	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	5.37	1.53	1.53	1.72	1.92	0.38	2.11	2.68	0.38	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	4.29	1.02	1.02	0.82	2.45	0.61	2.04	1.43	0.00	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	4.03	0.81	1.81	1.41	1.61	0.81	3.22	0.81	0.00	3.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	4.05	0.54	0.81	2.16	1.89	0.27	3.24	2.16	0.27	3.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	1.20	0.72	1.20	0.48	0.96	0.48	2.40	1.92	0.24	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	3.53	0.47	0.71	1.41	1.65	0.24	2.12	1.65	0.24	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	2.34	0.88	1.46	1.32	1.76	0.44	3.66	1.46	0.29	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	2.95	1.69	1.69	1.90	1.48	0.63	2.95	2.95	0.63	3.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	2.80	1.22	2.10	1.40	2.45	0.35	4.72	1.92	0.35	4.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	5.22	1.61	1.61	1.00	2.01	0.60	6.02	1.00	0.40	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	3.95	1.63	0.93	1.40	1.16	0.93	5.58	1.40	0.70	4.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	5.04	0.96	1.92	1.68	2.40	1.44	3.12	1.44	0.00	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	2.98	1.79	0.60	2.09	1.79	0.60	3.28	1.19	0.30	3.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	3.35	1.68	1.68	1.44	1.20	0.48	5.98	2.15	0.24	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	3.24	0.81	1.82	1.62	1.62	0.81	6.27	2.43	0.40	8.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	4.30	1.64	1.84	2.25	3.07	1.43	4.92	1.23	0.41	7.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	5.11	0.89	1.33	2.45	1.78	0.44	6.67	1.33	0.22	8.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	27.98	0.00	13.99	0.00	13.99	0.00	13.99	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.32	1.77	2.13	2.13	2.48	0.35	5.68	4.26	1.06	6.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	3.98	1.66	1.33	1.66	0.99	1.66	4.31	1.99	0.33	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	4.19	2.52	8.39	0.84	0.00	0.84	5.03	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1.38	0.46	0.92	0.00	0.92	0.92	5.97	2.76	0.00	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.86	0.97	0.97	0.97	1.62	0.65	4.86	2.59	0.00	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.82	1.93	0.96	1.93	2.57	2.25	4.18	2.25	0.64	5.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.34	1.26	3.14	0.94	2.20	0.94	5.03	2.83	0.63	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	1.41	0.71	0.00	0.71	2.12	1.41	0.00	2.82	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1.68	0.56	0.56	0.00	1.12	1.12	2.80	1.68	0.00	6.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	0.00	7.96	2.39	1.59	2.39	3.98	3.98	0.00	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3.06	0.68	1.02	1.36	0.34	0.00	6.80	2.72	0.34	4.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.82	2.27	0.97	0.97	0.00	0.65	2.60	3.57	0.00	4.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.97	1.06	1.06	0.35	0.35	0.71	3.19	1.42	0.00	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	16.16	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	0.00	39.49	0.00	0.00	7.90	0.00	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	1.46	0.00	0.49	1.46	0.00	0.98	2.44	1.46	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	1.49	0.99	0.00	0.50	0.50	0.00	0.50	0.50	0.00	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	2.35	0.47	0.00	1.41	0.00	0.00	2.35	1.41	0.00	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	2.65	0.66	1.66	0.00	0.33	0.33	1.32	2.65	0.33	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	2.78	1.24	0.00	0.31	0.93	1.24	0.62	0.62	0.00	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.06	0.61	0.31	1.22	0.00	1.22	1.22	1.53	0.61	2.14
Adipocyte - breast, donor1	11376-118A8	1.74	1.27	2.69	3.80	1.11	0.63	2.38	0.16	1.11	0.79
Adipocyte - breast, donor2	11327-117E4	3.21	0.96	1.60	4.49	3.37	0.32	0.80	0.96	1.12	3.05
Adipocyte - omental, donor1	11473-119C6	2.29	1.91	2.16	5.98	2.93	0.13	1.78	0.76	0.64	1.53
Adipocyte - omental, donor2	11474-119C7	2.24	0.00	0.00	1.49	0.75	0.00	0.00	0.75	0.75	2.24
Adipocyte - omental, donor3	11475-119C8	2.01	0.67	0.33	5.69	3.68	0.00	2.01	0.67	0.00	1.67
Adipocyte - perirenal, donor1	11476-119C9	2.55	1.28	0.64	4.47	1.91	0.64	1.28	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	0.00	4.40	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	1.35	0.45	0.45	2.26	0.90	0.45	1.81	0.00	0.90	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	3.65	0.52	2.43	15.81	8.34	0.52	2.61	1.04	0.87	3.82
Adipocyte differentiation, day04, donor1	13019-139D4	6.65	4.11	2.54	18.97	6.45	0.98	2.93	0.78	3.52	5.87
Adipocyte differentiation, day04, donor2	13022-139D7	9.27	4.38	1.54	4.89	2.83	1.29	4.63	1.54	1.29	3.35
Adipocyte differentiation, day04, donor3	13025-139E1	4.46	0.84	1.95	7.81	2.79	1.67	2.79	1.95	2.23	4.18
Adipocyte differentiation, day04, donor4	13028-139E4	12.34	2.35	2.35	19.99	9.99	0.59	6.47	2.35	2.94	4.70
Adipocyte differentiation, day08, donor1	13020-139D5	7.40	4.91	2.41	33.14	9.73	0.88	4.50	2.01	2.25	3.46
Adipocyte differentiation, day08, donor2	13023-139D8	9.68	0.65	1.94	15.17	5.16	0.32	3.55	1.29	0.97	3.55
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	1.07	1.60	11.73	6.40	0.00	1.60	0.53	2.67	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	7.79	2.78	0.56	12.24	8.90	1.11	3.34	0.56	2.78	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	5.41	1.25	2.50	13.31	7.49	0.42	0.83	1.25	0.00	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	4.52	0.75	4.27	11.80	4.77	0.50	1.51	0.50	0.75	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	10.80	1.64	1.64	6.87	3.93	0.33	2.62	0.00	1.64	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	6.39	1.52	0.00	9.74	6.39	0.30	0.91	1.52	0.30	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	5.30	2.65	0.44	4.42	1.77	1.99	6.19	1.33	1.99	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	2.51	0.00	10.40	2.15	1.08	1.79	1.08	0.72	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	1.20	0.00	2.40	2.40	0.00	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.30	1.80	1.44	8.46	2.16	0.72	4.86	1.26	1.44	2.52
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	0.00	1.67	8.37	5.02	1.67	6.69	1.67	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.55	1.64	3.08	4.93	2.47	0.21	2.67	1.64	1.23	2.47
Anulus Pulposus Cell, donor1	11248-116E6	1.03	0.92	5.49	2.06	1.60	0.11	0.92	0.23	0.11	1.03
Anulus Pulposus Cell, donor2	11463-119B5	2.94	0.73	2.20	3.67	1.96	0.00	1.22	0.49	0.73	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	1.80	0.90	0.45	1.80	0.00	1.35	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	0.87	0.87	0.87	0.43	0.43	1.30	0.43	0.43	0.43	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	0.00	0.00	2.14	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	1.79	1.20	0.60	0.90	0.60	0.90	0.30	1.20	0.30	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	0.00	3.79	2.53	0.00	0.00	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	2.64	0.66	0.00	1.32	0.66	1.32	0.66	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	1.95	0.65	0.32	1.62	0.65	0.32	0.32	0.32	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	3.88	1.94	1.46	0.00	0.00	0.97	0.00	0.49	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.38	0.59	0.59	0.59	0.59	0.00	0.00	0.59	0.59	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	2.64	2.26	0.75	0.38	0.75	0.38	0.00	0.00	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	0.00	0.00	0.73	0.73	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	0.00	0.00	0.00	0.00	0.00	0.00	1.25	0.00	0.00	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	1.32	1.98	0.66	0.49	0.49	0.49	0.66	0.82	0.33	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	0.00	0.00	0.00	0.00	0.00	0.00	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	1.51	3.47	0.45	0.75	0.45	0.75	0.15	0.30	0.30	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	2.68	0.54	1.07	1.07	1.07	0.00	0.54	0.54	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	1.89	1.51	0.57	0.38	0.38	0.57	0.19	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	2.14	2.14	0.00	0.80	0.27	0.80	1.34	0.00	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	2.93	0.00	1.95	0.00	0.98	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	1.00	1.66	1.00	0.66	0.33	0.50	0.83	0.66	0.66	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	0.00	1.20	0.00	0.00	0.00	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	3.54	0.00	0.00	0.00	0.00	0.00	0.00	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	2.23	0.86	1.03	0.86	0.86	0.17	0.86	0.34	0.51	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	4.19	0.00	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	2.91	0.49	0.49	0.49	0.97	0.97	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	3.04	2.28	1.52	0.76	0.76	1.14	0.76	0.76	1.90	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	1.21	1.21	0.00	0.00	1.21	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	1.71	2.85	0.00	0.00	0.57	1.14	0.57	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	2.35	0.86	0.64	1.50	0.00	0.43	0.43	0.21	0.43	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	1.55	1.29	0.26	0.52	0.26	0.26	0.52	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	1.88	0.94	0.47	0.00	0.47	0.47	0.00	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	1.61	0.96	0.00	0.32	0.64	0.96	0.32	1.29	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	1.43	1.43	0.00	1.43	0.71	2.14	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1.17	1.17	0.00	0.58	0.00	0.58	0.00	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	2.11	2.71	0.60	2.41	0.30	1.20	0.00	0.60	0.60	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	0.00	1.19	0.00	0.00	0.00	1.19	0.00	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	3.05	0.51	0.00	0.51	0.00	0.51	0.00	0.00	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	2.80	2.04	1.02	0.51	0.00	0.51	0.76	0.00	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.27	0.00	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	1.73	1.29	0.43	1.73	0.43	1.73	0.00	0.00	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	2.12	2.12	0.42	0.85	0.21	0.21	0.00	0.42	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	0.58	1.16	0.00	0.58	0.29	0.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	1.89	2.83	0.00	0.00	0.94	1.89	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	2.20	1.36	0.34	0.68	0.17	1.02	0.51	0.17	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	2.32	6.95	2.32	0.00	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	2.11	0.00	0.00	0.00	2.11	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	2.36	1.72	0.86	0.21	0.00	0.21	0.43	0.43	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	1.20	1.20	0.60	0.60	0.00	1.20	0.60	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	0.73	0.00	0.00	0.00	0.73	0.73	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	2.07	1.15	0.23	0.92	0.23	0.46	0.69	0.00	0.00	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	0.00	2.03	0.00	1.02	0.00	0.51	0.51	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	1.24	1.03	0.41	0.21	0.21	0.21	0.83	0.41	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	0.92	1.22	0.31	0.61	0.00	0.31	0.61	0.00	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	2.87	0.00	0.48	0.96	0.48	0.48	0.48	0.00	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	1.11	2.66	0.67	0.67	0.22	0.89	1.11	0.00	0.22	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	0.00	3.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	1.11	1.11	1.11	0.55	0.55	0.55	0.00	1.66	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	1.59	1.59	0.53	0.26	0.00	0.53	0.79	0.79	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1.45	1.09	0.36	0.36	0.73	0.36	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.33	3.93	3.56	2.95	3.07	1.47	2.09	1.35	1.11	3.93
Astrocyte - cerebellum, donor2	11580-120F5	4.45	3.25	2.40	4.62	3.94	0.86	2.40	2.74	1.03	3.77
Astrocyte - cerebellum, donor3	11661-122F5	7.97	2.10	1.68	2.73	2.73	1.05	2.10	1.68	1.26	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	10.46	5.93	2.44	5.58	6.62	1.05	1.39	1.39	1.05	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	13.43	5.18	1.13	4.04	4.37	1.29	4.37	3.56	2.10	3.07
Astrocyte - cerebral cortex, donor3	11392-118C6	8.20	8.65	0.75	4.33	6.41	2.54	1.34	4.03	1.79	2.09
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	15.60	5.50	1.95	5.28	2.29	3.90	16.86	6.31	1.95	6.08
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	16.66	5.51	1.50	5.01	1.88	4.51	15.91	4.26	1.63	4.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.73	4.44	2.50	4.44	1.93	3.41	18.09	5.12	0.80	7.17
Basophils, donor1	12241-129G9	1.57	3.40	3.40	1.83	1.05	2.09	0.78	0.26	2.09	3.40
Basophils, donor2	12242-129H1	2.53	1.44	5.05	1.44	1.44	1.08	1.80	0.36	0.00	2.53
Basophils, donor3	12243-129H2	5.44	2.35	3.38	1.91	1.62	0.73	0.59	1.03	1.32	1.62
Bronchial Epithelial Cell, donor1	11511-119G8	5.82	1.29	2.37	0.43	0.22	0.43	0.22	0.22	2.16	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	6.86	1.83	2.74	0.00	0.46	0.91	2.74	0.91	1.37	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.14	0.63	0.63	0.63	0.00	0.00	0.63	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	3.54	1.46	0.83	0.21	0.83	0.83	0.62	1.04	0.21	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	1.15	0.69	2.53	0.69	0.00	0.46	0.46	0.69	1.15	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	4.14	0.90	3.24	0.36	0.54	0.18	0.36	0.54	0.54	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.49	0.10	9.17	4.12	6.80	0.31	6.08	1.34	0.00	1.75
Burkitt's lymphoma cell line:RAJI	10476-106I8	50.77	19.10	13.04	2.79	3.03	10.01	6.29	6.75	0.23	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	13.75	22.06	4.48	0.64	1.60	14.71	0.96	0.64	0.00	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	10.34	0.00	0.00	0.00	20.68
CD14+ Monocytes, donor1	11224-116B9	4.51	3.38	2.82	1.13	2.82	3.38	1.13	0.00	1.13	3.38
CD14+ Monocytes, donor2	11305-117B9	9.47	3.34	5.01	2.41	2.23	2.23	0.56	0.93	2.23	3.90
CD14+ Monocytes, donor3	11381-118B4	6.81	1.54	4.17	1.10	2.41	0.66	0.44	1.32	0.00	5.05
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	9.34	1.98	2.55	7.36	4.25	1.42	2.26	3.40	3.68	5.94
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	11.37	2.27	8.34	5.69	2.65	1.52	4.17	1.14	3.03	6.44
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	11.51	5.26	5.92	11.18	3.62	1.64	4.93	1.64	1.64	6.90
CD14+ monocytes - mock treated, donor1	11863-125A9	3.76	2.60	3.61	3.61	1.59	1.16	0.58	0.72	0.43	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	3.32	2.41	1.51	1.21	0.30	0.00	0.30	0.00	0.91	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	4.97	1.90	2.84	4.26	0.47	0.71	1.18	2.13	0.47	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.84	1.67	1.34	0.33	0.67	0.84	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.66	1.10	0.55	0.83	0.55	0.00	0.00	0.00	0.28	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.48	1.98	0.25	1.24	0.74	0.00	0.74	0.00	0.25	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.55	0.78	0.39	10.18	1.76	0.59	4.11	0.00	0.20	2.35
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.67	2.31	1.07	7.30	1.42	0.89	3.03	0.18	0.18	3.20
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.87	1.52	0.87	8.92	1.09	1.52	2.61	0.00	0.44	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.34	2.81	1.64	1.17	1.40	0.70	0.23	0.70	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.58	2.64	1.58	3.17	1.06	0.53	0.00	0.53	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	3.33	0.00	3.33	1.11	2.22	0.00	0.00	1.11	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	2.83	2.83	0.89	0.59	0.74	0.74	0.74	0.45	1.19	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.20	2.79	0.40	0.60	0.20	0.20	0.60	0.20	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.83	1.46	1.87	0.42	0.42	0.21	0.00	0.42	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.97	4.80	0.23	1.14	0.23	1.14	0.23	0.23	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.23	3.62	0.68	0.45	0.45	0.90	0.00	0.00	0.68	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.18	0.87	0.44	0.87	0.87	0.87	0.44	0.44	0.44	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.34	1.08	2.42	22.33	2.69	0.54	4.57	0.00	0.00	10.49
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.92	1.40	1.92	16.92	4.88	1.22	6.63	0.52	1.05	7.33
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2.95	0.84	0.42	29.46	4.63	0.42	7.15	0.00	0.42	8.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.29	2.02	0.37	0.37	0.55	0.73	0.00	0.18	0.73	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.11	1.76	1.06	0.70	0.35	1.41	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.58	0.88	0.00	0.88	0.00	0.88	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.66	1.57	1.05	8.54	1.74	1.05	2.96	0.35	1.05	3.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.23	3.35	0.37	5.95	1.86	0.74	4.09	0.00	0.74	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1.08	1.94	1.72	6.90	1.29	0.43	3.45	0.22	0.22	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	3.69	1.64	1.64	1.64	0.00	1.23	1.23	1.64	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.93	3.71	0.70	0.70	0.00	0.70	0.46	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.93	0.46	0.46	0.23	0.23	0.00	0.46	0.00	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	1.96	1.53	10.03	1.09	1.31	1.31	0.65	0.00	1.96	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	2.31	3.46	6.70	0.69	0.46	3.00	0.46	0.69	2.77	1.85
CD14+CD16+ Monocytes, donor3	11912-125G4	2.82	1.95	7.15	0.87	0.43	0.22	0.43	0.22	1.52	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	6.85	3.89	12.77	1.87	1.87	1.87	0.62	1.40	1.87	3.43
CD14+CD16- Monocytes, donor2	11799-124C8	2.97	3.32	5.41	2.10	1.05	1.22	0.70	1.22	1.40	2.97
CD14+CD16- Monocytes, donor3	11910-125G2	4.24	4.68	12.49	3.12	1.78	3.34	1.56	0.67	4.46	4.91
CD14-CD16+ Monocytes, donor1	11790-124B8	2.04	7.91	9.70	1.28	0.51	4.85	0.77	0.77	2.81	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	2.85	6.59	3.73	0.88	0.88	3.07	0.44	1.32	3.29	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	0.84	3.37	8.63	0.63	0.63	4.63	0.42	0.84	1.89	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	34.55	16.26	6.10	0.00	12.19	4.06	0.00	4.06	10.16
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	7.46	28.48	16.27	3.39	2.03	14.24	4.75	1.36	2.03	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	9.32	33.14	7.25	1.04	2.07	16.57	3.11	1.04	2.07	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.53	34.11	14.93	2.67	1.60	15.99	5.86	0.53	2.13	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.90	24.66	13.94	2.68	2.14	16.08	6.43	0.00	3.75	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.72	22.46	16.85	4.91	4.91	26.67	4.21	0.00	2.81	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	10.98	25.10	13.33	3.92	0.78	15.69	7.84	0.00	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	26.37	10.55	1.32	0.00	25.05	10.55	0.00	2.64	7.91
CD19+ B Cells, donor1	11544-120B5	51.78	44.38	18.90	0.82	8.22	33.70	4.93	4.93	6.58	9.04
CD19+ B Cells, donor2	11624-122B4	32.64	29.02	14.51	2.18	3.63	17.41	4.35	2.18	3.63	5.08
CD19+ B Cells, donor3	11705-123B4	39.38	32.31	17.16	1.01	5.05	18.17	3.03	3.03	3.03	5.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.85	0.40	0.00	0.00	0.00	0.40	0.00	1.21	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	3.20	1.20	0.80	0.00	0.00	1.20	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	10.04	26.11	9.04	3.01	5.02	20.08	0.00	0.00	1.00	2.01
CD34+ Progenitors, donor2	11625-122B5	10.67	17.98	2.81	0.56	1.69	9.55	0.00	1.69	1.69	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	12.02	10.52	7.52	0.38	1.88	7.89	1.13	2.25	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2.48	9.47	5.41	1.80	1.80	11.27	0.68	0.68	0.68	1.13
CD4+ T Cells, donor1	11225-116C1	21.07	0.00	36.06	3.93	5.36	0.00	7.14	2.86	0.00	4.64
CD4+ T Cells, donor2	11306-117C1	22.66	0.61	11.02	1.84	7.35	0.00	2.45	3.06	0.00	5.51
CD4+ T Cells, donor3	11382-118B5	18.30	0.61	18.60	1.83	4.88	0.00	4.27	1.83	0.00	6.10
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.16	0.26	15.06	0.51	1.79	0.77	1.28	2.30	0.26	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	20.44	3.14	7.41	1.57	1.35	2.92	1.57	1.12	0.67	3.14
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	18.40	0.57	17.54	1.44	0.86	1.44	1.72	1.15	0.57	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	10.43	0.95	26.08	2.37	1.42	2.37	6.16	0.95	0.00	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	7.73	3.51	25.28	2.11	4.21	2.11	1.40	1.40	0.00	4.92
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	0.00	13.18	3.30	3.30	0.00	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	10.26	4.91	5.93	0.87	0.58	4.19	1.88	1.30	1.01	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	19.49	4.41	5.59	2.54	1.02	4.74	1.02	1.86	1.02	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	18.70	5.48	6.29	1.29	0.81	3.55	1.13	1.61	0.48	2.58
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	10.31	5.38	14.79	1.34	1.34	4.03	2.24	0.45	0.45	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	14.32	4.19	8.04	1.05	1.05	2.45	1.75	1.05	0.00	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.48	1.76	16.72	3.96	1.32	2.20	5.28	1.32	0.00	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	7.17	2.95	14.34	2.11	1.69	2.53	2.11	2.11	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.88	1.87	5.61	3.53	1.25	2.49	1.87	2.08	0.21	3.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	13.03	2.67	4.68	3.01	2.00	2.67	1.34	1.34	0.33	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	32.09	0.27	40.25	0.82	2.72	0.00	4.89	2.72	0.00	3.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	47.16	1.07	44.48	1.61	2.68	0.00	4.82	1.61	0.00	3.75
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	19.73	0.00	48.42	0.00	1.79	0.00	1.79	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	14.09	2.60	6.12	0.56	1.30	1.67	5.01	1.85	0.19	2.04
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.33	0.43	3.68	2.17	0.87	2.17	3.25	0.43	0.00	3.03
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.88	1.26	3.78	1.47	1.47	1.89	3.78	1.26	0.21	3.78
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	8.60	1.52	16.68	2.53	0.00	0.00	2.53	1.52	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	4.33	0.43	10.40	2.17	3.03	0.00	4.33	0.43	0.00	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	8.72	0.87	30.94	0.87	0.87	0.00	5.67	0.44	0.00	4.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	9.90	0.49	25.24	2.47	0.99	0.49	9.90	1.48	0.00	4.95
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	7.39	0.00	17.54	2.77	1.85	0.00	2.77	0.00	0.00	8.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	0.00	12.56	1.40	0.00	0.00	2.79	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	10.25	0.00	26.31	1.94	1.11	0.55	3.05	1.38	0.28	3.88
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	10.31	0.00	22.58	0.74	0.74	0.74	3.19	1.23	0.49	4.91
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	0.00	21.56	3.08	0.00	0.00	4.62	0.00	0.00	7.70
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	5.01	0.00	20.41	1.79	0.72	0.00	4.66	0.72	0.36	4.66
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	4.15	0.00	12.46	0.00	1.38	1.38	9.69	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	26.19	0.00	11.13	2.95	2.95	0.33	7.20	2.62	0.00	7.53
CD8+ T Cells, donor2	11307-117C2	20.27	1.13	3.38	1.13	5.63	0.38	3.75	2.25	0.00	5.26
CD8+ T Cells, donor3	11383-118B6	25.75	1.26	7.83	1.51	2.27	0.25	7.83	3.53	0.00	9.09
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.05	0.23	0.00	0.00	0.00	0.92	0.92	0.69	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.51	0.48	0.00	0.48	0.00	0.72	1.68	0.72	0.96	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.83	0.55	0.00	0.27	0.00	0.00	0.82	0.00	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	2.40	0.00	0.00	0.90	0.60	0.60	3.30	0.90	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.84	0.48	0.00	0.24	0.00	0.48	2.64	0.96	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.87	0.68	0.00	0.23	0.23	0.68	2.73	0.68	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	7.17	0.87	0.22	0.87	0.22	0.65	1.96	0.87	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.79	0.79	0.00	0.53	0.00	0.79	1.58	0.26	0.26	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.04	0.23	0.00	0.00	0.23	0.47	1.17	0.47	0.00	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.25	0.91	0.00	0.60	0.60	0.91	1.81	0.60	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	1.16	0.00	0.29	0.00	0.87	0.58	1.16	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	5.60	0.27	0.27	0.53	0.00	0.80	1.33	1.07	0.27	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	27.14	1.75	0.00	0.88	0.44	0.88	3.06	2.19	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	34.61	1.82	0.00	1.37	0.00	1.82	3.19	2.73	1.82	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.06	3.73	0.00	3.73	0.00	0.75	2.24	2.24	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.96	0.72	0.00	0.36	0.36	0.36	2.88	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.63	1.15	0.00	0.86	0.29	0.58	2.88	0.86	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.48	0.00	0.00	1.18	0.47	1.18	1.65	1.65	0.71	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.34	0.32	0.00	0.32	0.63	1.27	1.90	1.90	0.32	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	5.54	0.62	0.00	0.62	0.00	0.00	3.08	0.31	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.17	0.96	0.00	0.96	0.32	0.96	2.24	2.24	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.74	1.15	0.00	0.00	0.00	1.15	0.76	0.76	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	7.49	0.39	0.00	0.00	0.39	1.18	1.97	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.92	4.01	0.00	0.00	1.61	1.61	2.41	3.21	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.77	4.20	0.70	1.40	0.70	0.70	4.20	4.90	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	2.00	1.00	1.00	0.00	0.00	2.00	3.01	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	29.24	0.00	5.48	20.11	5.48	0.00	0.00	1.83	5.48	12.79
Cardiac Myocyte, donor2	11605-120I3	10.38	1.48	0.49	4.94	0.99	0.49	2.96	1.48	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	1.58	0.95	0.63	6.63	1.37	0.32	2.84	0.42	1.58	1.79
Chondrocyte - de diff, donor1	11261-116G1	3.81	0.00	0.69	1.39	2.08	0.35	0.35	0.69	0.00	1.73
Chondrocyte - de diff, donor2	11338-117F6	3.55	1.42	2.49	3.20	1.42	0.00	0.00	0.36	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	1.93	0.23	1.82	1.93	2.16	0.11	1.02	0.80	0.23	0.68
Chondrocyte - re diff, donor2	11339-117F7	6.27	2.69	0.90	2.69	0.90	3.58	2.69	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	5.66	1.21	3.24	2.83	5.66	0.40	0.81	1.62	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	7.80	2.98	2.64	1.38	1.95	1.03	3.56	2.87	0.57	2.41
Ciliary Epithelial Cells, donor2	11323-117D9	7.91	3.21	1.28	2.57	0.64	1.92	2.57	1.92	0.86	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	8.76	3.36	1.24	1.50	1.95	0.97	1.77	3.98	0.71	2.48
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	27.42	9.35	18.43	12.47	11.10	3.85	7.61	4.49	4.95	5.59
Corneal Epithelial Cells, donor1	11526-119I5	3.95	3.29	5.05	0.22	0.22	1.32	1.54	1.10	1.98	0.66
Corneal Epithelial Cells, donor2	11606-120I4	2.28	3.41	4.55	2.28	0.00	3.41	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.60	0.51	1.79	0.51	0.51	0.26	0.26	0.51	0.51	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	2.64	3.47	6.44	1.16	0.17	0.99	0.83	0.66	5.12	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	3.15	3.78	5.36	0.32	0.32	2.84	0.95	1.26	6.62	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	10.35	0.00	0.00	0.00	3.45	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.62	1.73	4.97	0.65	0.22	0.22	0.76	1.19	3.02	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	18.11	2.73	5.81	3.42	2.73	8.20	6.49	1.37	1.02	12.64
Dendritic Cells - plasmacytoid, donor2	11309-117C4	9.79	3.92	5.88	3.92	1.31	4.57	7.18	0.00	0.00	13.06
Dendritic Cells - plasmacytoid, donor3	11385-118B8	10.65	3.87	6.78	2.42	3.39	4.36	9.19	0.00	0.97	6.78
Endothelial Cells - Aortic, donor0	11207-116A1	4.50	11.34	0.00	3.00	1.17	2.67	1.33	0.67	5.50	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	11.74	2.93	0.59	2.35	0.59	1.17	1.17	0.00	1.76	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	12.73	12.16	0.00	3.11	0.85	3.68	0.85	2.26	1.98	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	6.68	11.80	0.00	3.54	0.39	3.15	1.18	1.57	2.75	1.57
Endothelial Cells - Artery, donor1	11264-116G4	9.31	5.24	0.00	2.04	0.58	1.16	0.87	0.87	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	11.29	3.76	0.00	1.65	1.41	2.12	0.47	1.88	1.65	0.71
Endothelial Cells - Artery, donor3	11413-118E9	5.79	7.71	0.00	3.33	0.70	1.75	1.23	1.23	1.93	2.10
Endothelial Cells - Lymphatic, donor1	11236-116D3	9.09	5.10	0.89	3.77	1.33	1.77	1.11	1.77	1.11	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	16.13	7.61	2.13	6.39	2.13	2.43	2.43	2.43	2.13	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.68	11.56	0.00	5.92	2.54	3.38	1.69	4.23	4.51	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	13.07	0.59	0.89	0.89	0.89	0.30	0.89	2.67	1.78	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	12.50	5.21	0.52	2.60	0.52	0.52	4.17	1.04	1.04	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	12.62	1.99	0.57	3.40	0.99	0.43	0.85	1.56	0.43	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	9.60	6.00	0.00	4.00	0.80	1.60	1.20	0.00	2.40	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	3.14	0.00	0.52	1.57	1.57	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	13.17	10.19	0.25	3.98	1.99	3.23	3.48	2.73	4.35	3.85
Endothelial Cells - Umbilical vein, donor2	11324-117E1	18.68	7.17	0.22	2.61	1.09	1.74	1.52	4.56	5.21	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.62	10.38	0.12	4.40	1.22	4.40	4.15	7.08	6.35	2.08
Endothelial Cells - Vein, donor1	11267-116G7	9.10	5.69	0.00	0.00	2.28	5.69	2.28	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	12.57	4.89	0.00	4.89	0.70	6.99	3.49	1.40	3.49	1.40
Endothelial Cells - Vein, donor3	11416-118F3	8.64	7.38	0.31	1.88	0.31	2.36	1.57	1.73	2.36	1.26
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	6.60	1.65	26.40	0.00	1.65	9.90	0.00	0.00	11.55
Eosinophils, donor3	12246-129H5	3.57	0.00	3.57	24.97	0.00	0.00	14.27	0.00	0.00	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	3.42	1.95	2.20	0.00	0.49	0.98	0.49	0.73	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.28	4.52	0.82	2.05	2.46	1.23	1.23	0.41	1.23	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	0.11	0.44	0.33	1.86	0.88	0.11	0.66	0.22	0.33	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	0.54	0.87	0.33	1.73	0.98	0.43	0.22	0.65	0.22	2.17
Fibroblast - Aortic Adventitial, donor1	11245-116E3	1.58	2.67	1.21	2.30	1.70	1.09	1.70	0.12	1.70	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	4.78	5.46	1.91	4.91	1.77	2.18	1.23	2.46	2.18	1.77
Fibroblast - Aortic Adventitial, donor2	11326-117E3	1.05	1.27	0.42	5.38	1.48	1.05	2.21	0.74	0.95	3.06
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.54	4.74	2.63	3.95	1.58	1.84	0.79	2.37	2.63	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	2.33	3.32	1.33	5.32	1.33	0.33	2.66	1.33	1.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	2.27	3.63	0.45	4.54	0.91	0.00	2.72	0.91	1.36	1.36
Fibroblast - Cardiac, donor2	11345-117G4	3.79	6.06	0.00	2.27	0.00	2.27	1.52	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	3.31	4.10	0.16	1.73	0.63	0.63	0.79	0.16	1.10	0.63
Fibroblast - Cardiac, donor4	11452-119A3	8.49	5.46	6.67	13.03	6.97	1.21	2.73	0.91	1.52	5.46
Fibroblast - Cardiac, donor5	11456-119A7	4.57	7.11	0.13	6.60	2.79	1.78	0.89	1.52	2.03	1.90
Fibroblast - Cardiac, donor6	11460-119B2	5.61	6.06	1.67	8.49	2.43	1.21	2.12	1.36	1.67	2.88
Fibroblast - Choroid Plexus, donor1	11492-119E7	8.31	5.63	4.96	4.02	3.62	0.80	1.21	1.47	2.14	4.02
Fibroblast - Choroid Plexus, donor2	11572-120E6	5.18	3.45	2.16	3.02	1.73	0.00	0.86	0.43	0.86	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	0.00	1.46	1.46	2.93	1.46	2.93	0.00	0.00	0.00	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	3.46	8.53	0.92	6.92	5.30	6.23	0.92	2.54	1.61	2.77
Fibroblast - Conjunctival, donor3	11692-122I9	4.75	1.02	5.60	3.05	4.58	0.34	0.51	1.19	1.87	1.70
Fibroblast - Dermal, donor1	11269-116G9	1.88	0.47	0.70	2.35	0.47	0.00	1.17	0.23	0.70	1.17
Fibroblast - Dermal, donor2	11346-117G5	3.77	1.89	2.83	2.83	0.47	1.89	0.47	1.42	0.94	2.36
Fibroblast - Dermal, donor3	11418-118F5	1.45	1.09	0.73	2.78	1.09	0.48	1.09	0.24	1.21	0.97
Fibroblast - Dermal, donor4	11450-119A1	3.84	5.65	0.90	4.63	2.03	2.94	2.03	1.47	2.03	2.60
Fibroblast - Dermal, donor5	11454-119A5	6.28	6.11	1.05	5.41	2.97	3.31	1.22	1.92	2.09	2.27
Fibroblast - Dermal, donor6	11458-119A9	5.85	6.82	0.81	4.71	2.76	3.41	0.49	1.95	1.30	2.11
Fibroblast - Gingival, donor1	11237-116D4	2.29	2.71	2.92	3.33	1.04	1.04	1.25	1.04	1.25	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	3.14	1.31	4.72	2.36	1.05	0.26	0.79	1.57	1.57	0.52
Fibroblast - Gingival, donor2	11318-117D4	3.29	5.14	1.32	3.69	1.98	1.71	1.05	1.58	1.84	0.92
Fibroblast - Gingival, donor3	11394-118C8	3.58	1.74	3.09	4.64	3.58	0.77	0.19	1.74	0.97	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	3.12	8.31	1.04	1.04	0.00	1.04	0.00	0.00	7.27	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	3.52	5.99	0.35	0.70	0.70	3.17	0.00	1.06	3.17	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	2.81	0.94	2.65	1.71	0.62	0.62	0.78	1.09	0.94	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	1.89	2.57	1.89	2.16	0.54	1.49	0.27	0.54	2.30	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.23	0.71	4.23	4.94	2.12	0.35	3.18	1.76	0.35	4.59
Fibroblast - Gingival, donor7 (control)	11924-125H7	1.75	2.49	3.66	1.75	0.88	0.88	0.44	0.88	1.75	2.05
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	2.59	1.09	4.36	3.00	0.55	0.55	0.95	0.95	0.82	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	2.19	3.51	1.43	2.63	0.44	1.65	0.22	0.55	2.30	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	5.43	4.11	1.91	0.73	0.44	2.35	0.15	1.91	3.52	1.76
Fibroblast - Lung, donor1	11270-116H1	4.08	4.08	4.08	12.23	1.36	1.36	1.36	1.36	4.08	1.36
Fibroblast - Lung, donor2	11347-117G6	5.97	1.49	4.48	7.46	1.49	0.00	1.49	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	1.69	1.48	1.48	2.74	0.21	1.48	2.11	0.84	0.84	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	7.50	2.50	14.99	29.99	5.83	2.50	4.17	1.67	4.17	10.83
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	1.40	2.80	13.99	2.80	0.00	1.40	0.00	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	2.52	1.96	2.80	9.24	3.64	0.84	1.40	1.40	1.12	6.16
Fibroblast - Mammary, donor1	11540-120B1	3.65	6.90	3.25	15.02	4.87	3.65	4.47	1.62	1.62	7.71
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	3.99	19.97	3.99	3.99	0.00	3.99	3.99	7.99
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	11.91	0.00	0.00	0.00	11.91	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	3.30	5.04	1.94	1.36	2.52	2.52	1.16	0.97	1.75	1.75
Fibroblast - Periodontal Ligament, donor2	11319-117D5	7.43	8.65	2.73	7.43	3.94	5.16	1.97	3.19	4.40	3.79
Fibroblast - Periodontal Ligament, donor3	11395-118C9	3.06	2.45	3.06	7.04	2.14	0.92	1.22	0.92	3.06	2.75
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	2.67	4.58	1.91	1.91	0.38	0.76	0.38	1.14	0.76	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	0.54	2.97	0.81	2.16	1.62	1.08	0.27	1.35	0.27	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	2.20	12.41	0.46	1.28	0.93	5.33	0.12	0.81	3.13	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	0.33	1.44	0.22	2.43	0.77	1.11	0.88	0.33	0.33	1.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.08	16.26	2.84	26.21	4.88	2.44	6.71	1.83	7.92	7.31
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.00	6.01	3.34	8.02	4.68	2.67	0.67	0.67	2.67	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	1.19	0.40	0.79	1.58	1.98	0.79	0.40	0.40	0.40	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.12	2.58	10.12	3.57	0.99	1.59	0.99	3.37	1.39	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	3.37	1.78	2.31	2.84	1.24	0.89	1.60	0.36	0.18	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	3.15	0.99	0.79	3.74	2.37	0.59	1.38	0.39	1.58	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.32	1.50	7.22	1.20	0.90	1.20	0.30	0.90	0.60	3.91
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	3.02	1.08	2.16	3.99	0.97	0.54	1.51	0.76	1.08	2.81
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	7.34	2.53	4.30	2.53	1.01	0.25	0.51	1.01	1.27	1.77
Fibroblast - skin normal, donor1	11553-120C5	2.95	0.66	1.31	2.46	0.49	0.33	1.31	0.66	1.15	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	6.02	2.21	5.61	2.21	1.20	0.40	0.80	3.01	1.60	2.81
Fibroblast - skin normal, donor2	11561-120D4	2.21	1.11	2.31	2.31	1.00	0.40	1.11	0.70	1.21	2.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.07	3.02	13.00	5.44	2.42	2.12	0.91	2.42	2.42	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	3.48	0.99	1.99	4.23	2.65	0.33	1.57	0.83	0.91	2.24
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	5.13	2.05	6.50	4.44	2.56	0.68	0.68	0.85	2.74	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	7.23	0.99	9.20	3.28	1.64	0.00	0.33	1.64	0.66	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	2.66	0.32	2.77	2.45	0.96	0.32	0.53	0.32	0.75	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	2.70	2.19	3.20	2.70	1.35	0.51	1.69	1.01	0.34	2.70
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	0.47	0.31	1.41	0.78	0.16	0.00	0.31	0.31	0.00	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	44.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	0.87	4.36	2.61	0.00	0.87	0.87	2.61	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	2.77	1.04	0.52	1.56	0.87	0.52	1.91	1.21	0.52	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	5.73	1.04	1.82	0.78	0.00	0.26	1.82	2.08	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	2.81	1.28	0.51	1.02	1.28	0.51	1.28	0.51	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	12.25	0.00	0.77	0.00	8.42	0.00	1.53	0.77	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.12	8.29	0.00	0.64	0.64	4.47	1.91	3.19	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.69	22.54	0.00	1.43	0.00	10.55	2.85	7.70	1.71	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	30.33	19.03	0.83	7.17	7.17	3.86	11.03	9.65	3.86	3.31
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.97	23.29	1.37	8.68	7.08	5.71	5.94	13.93	2.51	2.51
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	19.61	19.22	0.20	1.19	1.19	8.52	2.38	6.93	1.78	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	35.69	10.84	0.53	5.55	5.55	2.91	7.40	9.78	2.64	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	43.05	36.85	0.65	6.85	6.20	8.15	6.20	18.26	4.57	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	11.94	25.65	0.00	0.44	0.00	7.08	0.88	4.86	1.77	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	13.00	7.35	0.14	2.54	2.12	5.79	1.98	2.26	1.84	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	21.55	7.27	0.49	2.22	1.85	3.82	2.34	4.68	2.22	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.21	4.30	0.27	2.69	1.61	3.76	1.61	2.69	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	13.26	7.19	0.25	1.49	1.61	1.86	2.35	3.22	0.74	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.29	6.23	0.00	2.49	0.83	2.49	2.91	2.77	1.66	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	8.34	7.52	0.00	1.63	0.41	2.85	1.83	2.24	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	17.11	5.93	0.23	1.60	1.37	0.91	2.28	2.05	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.20	3.61	0.75	2.12	1.49	2.37	1.87	2.62	1.62	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.39	5.03	0.00	0.66	0.87	2.19	2.19	5.46	1.53	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.36	4.43	0.00	1.18	2.95	1.18	1.18	2.36	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.62	6.04	0.32	1.27	3.81	2.23	2.23	3.81	2.23	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	13.63	5.36	0.45	0.45	1.34	2.68	1.34	2.01	0.67	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	18.15	5.04	0.40	1.41	2.82	1.41	2.82	1.81	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	15.78	6.28	0.68	2.71	3.22	1.53	2.04	2.88	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.15	10.37	0.89	3.01	1.86	3.10	1.42	2.31	2.04	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.04	6.97	0.83	2.29	3.43	1.56	1.35	3.64	1.25	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.32	5.46	0.68	1.71	4.27	0.68	1.37	3.42	1.71	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.56	6.64	0.89	1.99	2.88	1.66	1.77	4.09	1.33	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.22	9.07	0.50	1.91	1.66	1.83	1.08	3.16	2.00	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.42	6.33	0.20	1.84	1.23	2.25	1.02	2.04	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.89	4.54	0.21	0.83	2.68	0.41	0.83	3.51	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	23.06	4.61	0.35	1.73	2.88	1.15	1.96	3.46	0.46	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.68	6.50	0.33	1.33	1.83	1.00	1.17	3.17	0.33	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.96	2.42	0.66	0.88	2.42	0.66	0.66	0.88	1.54	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	21.15	3.32	0.86	0.98	2.83	1.23	1.35	2.58	0.49	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.07	6.65	0.49	3.57	2.11	1.78	1.46	5.02	1.30	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.66	7.06	1.60	0.96	2.25	0.96	1.28	4.81	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.33	4.17	0.57	1.42	3.22	0.85	1.23	3.03	0.85	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.71	3.95	0.32	1.27	1.27	0.95	0.95	2.69	0.47	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.89	3.95	0.61	1.52	2.74	1.82	0.91	3.95	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	15.37	3.24	1.05	0.94	2.40	0.52	2.09	2.72	0.94	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.00	2.85	0.22	1.10	1.32	1.10	0.44	3.51	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.29	5.33	1.40	1.12	1.40	0.56	1.96	3.37	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.67	3.52	0.56	2.13	2.31	1.39	0.74	2.87	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.97	1.87	0.00	0.80	1.07	0.80	0.80	1.07	1.60	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.92	3.21	0.31	3.37	0.77	1.22	1.07	2.45	0.61	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	8.16	3.37	0.13	1.42	1.94	0.91	1.04	1.30	0.91	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	9.76	1.36	0.00	0.54	1.36	0.81	1.36	1.63	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.04	5.90	0.74	1.29	0.74	1.66	1.66	2.40	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.91	3.73	0.88	0.66	2.19	1.32	1.32	1.10	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	27.77	5.95	4.96	1.98	4.96	0.99	4.96	11.90	2.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	8.84	3.69	0.79	1.45	0.92	1.85	0.79	1.71	0.92	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.70	5.65	0.61	0.81	3.03	0.81	1.01	1.41	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	19.32	8.13	6.35	7.12	11.69	3.56	2.54	4.57	1.78	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.54	12.14	0.40	2.39	0.40	5.37	1.39	2.39	0.40	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	20.80	8.78	0.00	1.85	1.08	5.24	2.47	6.78	2.47	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.98	14.53	0.00	1.43	0.61	11.05	1.43	3.89	3.07	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.32	12.83	0.00	0.94	0.31	6.57	0.63	2.19	1.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.83	9.32	0.00	0.85	0.00	2.54	0.00	0.85	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	25.83	16.60	0.00	0.92	0.46	8.30	0.46	3.23	5.53	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	9.90	0.00	0.00	0.00	7.42	2.47	7.42	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.09	18.57	0.39	1.16	0.00	4.64	1.93	4.25	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	19.25	0.00	0.00	0.00	6.42	3.21	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	26.08	0.00	5.22	1.74	1.74	3.48	3.48	6.96	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	14.65	10.74	0.00	2.28	0.65	3.25	3.58	0.98	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	24.71	17.71	0.41	1.65	1.24	8.24	2.06	2.06	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	26.66	0.00	0.00	3.33	6.66	0.00	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	20.13	15.38	0.00	2.24	1.12	3.92	2.80	1.40	2.80	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.32	14.38	0.00	0.65	1.96	3.27	1.31	3.60	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.00	22.65	0.84	1.68	2.52	4.19	4.19	6.71	8.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.45	18.77	0.00	1.91	2.23	4.77	2.86	2.54	2.23	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	17.32	14.61	0.00	1.02	0.68	3.40	2.04	2.04	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	8.35	0.00	0.00	0.00	0.00	0.00	4.18	6.26	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	18.33	15.46	0.57	0.57	1.72	6.87	0.00	4.58	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.32	10.66	0.30	1.48	0.30	1.18	0.59	2.07	1.18	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	20.33	28.80	0.00	1.69	0.00	3.39	1.69	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	22.78	19.47	0.00	1.24	0.83	3.31	2.90	1.24	2.90	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	22.32	15.88	0.23	1.84	0.92	2.99	3.45	2.30	3.22	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	0.00	0.00	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.53	18.84	0.00	1.92	0.38	3.46	1.54	1.92	2.69	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	19.56	19.23	0.33	2.93	3.59	2.61	1.30	2.93	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	10.70	10.03	0.00	2.68	2.01	2.01	0.67	4.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	20.42	15.41	0.39	1.93	1.54	3.47	0.77	3.47	1.16	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.78	32.18	0.00	7.87	4.45	4.79	6.16	1.71	3.77	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	24.85	0.00	2.48	0.00	2.48	0.00	9.94	7.45	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.20	13.21	0.00	0.94	4.72	4.25	1.89	4.72	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	17.50	16.29	0.00	1.81	0.00	1.81	1.81	3.02	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	27.98	20.86	0.00	3.05	4.58	4.07	1.53	5.09	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	36.29	18.75	0.40	1.20	2.79	3.99	2.79	4.39	3.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	24.67	14.31	0.00	2.47	2.96	1.97	2.47	3.95	2.47	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	43.68	30.69	0.00	1.18	1.18	4.72	1.18	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.84	18.09	0.58	4.67	3.50	2.33	1.75	2.92	2.33	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	33.79	17.12	1.76	2.63	1.76	1.32	1.32	3.51	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	28.82	23.74	0.85	0.85	4.24	3.39	5.93	0.00	3.39	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.02	26.26	0.60	2.39	1.79	2.98	0.60	4.18	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	17.95	0.49	0.49	0.49	2.43	1.46	2.91	2.43	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	1.14	0.00	1.14	1.14	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	2.49	0.42	1.25	1.25	0.83	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	1.12	1.12	0.00	1.12	2.25	1.12	1.12	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	2.85	0.00	1.90	2.85	0.63	0.00	2.85	0.32	0.00	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	0.00	1.67	1.67	0.84	0.00	0.42	0.00	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	2.67	1.62	0.58	0.00	0.00	1.04	0.00	0.70	0.58	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.36	0.68	0.51	0.17	0.00	1.52	0.00	0.51	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.55	1.14	0.68	0.23	0.00	0.46	0.00	0.23	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	2.30	0.66	0.22	0.00	0.00	1.20	0.00	0.33	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	3.44	0.43	1.07	0.21	0.00	1.07	0.00	0.21	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.23	0.65	0.65	0.22	0.00	0.86	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.62	0.50	0.37	0.00	0.12	1.62	0.00	0.12	0.50	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	3.60	0.86	0.69	0.17	0.00	0.69	0.00	0.34	0.69	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.84	0.64	0.96	0.00	0.00	0.64	0.00	0.64	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.35	6.16	0.00	4.48	2.24	1.12	1.12	5.04	1.68	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	6.92	0.00	8.22	2.16	2.60	5.63	1.30	1.73	3.90
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	2.64	0.00	2.64	0.00	0.00	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.41	2.82	3.17	10.93	5.64	0.35	2.47	1.06	1.41	4.59
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	1.45	1.45	7.99	2.91	0.73	2.91	1.45	0.73	4.36
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	3.15	1.05	0.87	2.45	0.00	0.17	1.05	0.52	0.52	0.70
Hepatocyte, donor1	11523-119I2	10.90	0.00	3.63	1.21	2.42	2.42	3.63	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	9.70	2.15	1.08	6.46	2.15	2.15	2.15	1.08	3.23	1.08
Hepatocyte, donor3	11684-122I1	17.79	2.45	2.45	7.98	4.29	1.23	2.45	3.68	3.07	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	27.41	0.00	0.00	0.65	0.00	0.65	0.65	1.96	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.54	9.79	1.92	4.19	2.27	2.97	2.27	1.92	2.45	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	3.43	1.78	0.69	1.92	0.69	0.69	2.06	0.55	0.55	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	0.00	0.00	0.00	0.00	0.00	3.18	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	6.68	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	2.77	0.00	0.00	0.00	4.15	1.38	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	0.00	0.00	0.00	0.00	0.00	7.51	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	5.13	0.00	2.56	0.00	5.13	2.56	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	3.25	0.00	0.00	0.00	3.25	0.00	4.87	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	25.01	0.00	0.00	0.00	1.67	3.33	0.00	1.67	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	2.65	2.65	1.32	2.65	1.32	0.00	5.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	32.15	0.00	0.00	1.11	0.00	2.22	0.00	2.22	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00	0.00	5.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.79	2.52	0.63	0.00	1.89	0.00	0.63	1.89	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	0.00	3.09	1.55	0.00	0.00	0.00	4.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	14.63	0.00	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	20.67	1.29	0.65	0.65	0.65	5.17	0.00	2.58	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	0.00	0.00	1.61	0.00	0.00	1.61	3.22	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	23.63	0.00	0.81	1.63	1.63	2.44	1.63	2.44	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	19.31	0.42	0.84	1.26	0.00	0.84	0.00	3.36	0.84	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	27.33	0.80	0.80	0.00	0.00	3.21	0.80	4.82	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	1.85	0.92	0.00	0.00	0.00	0.00	4.62	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.16	0.00	0.47	0.00	0.47	0.47	0.47	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	18.14	0.91	0.00	0.00	0.00	0.91	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	0.00	0.00	2.15	0.00	0.00	4.30	3.23	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	0.00	0.00	0.00	1.27	1.27	0.00	2.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	20.41	1.28	0.00	0.00	0.00	1.28	0.64	3.19	1.91	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	41.92	0.00	0.00	0.00	0.00	1.82	1.82	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	2.14	0.71	0.71	0.71	3.57	0.71	4.28	1.43	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.06	0.62	0.31	0.31	0.93	0.31	0.62	4.01	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	1.76	0.00	1.76	0.00	0.00	1.76	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	3.14	0.00	0.00	0.00	0.00	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	36.86	0.70	1.39	0.70	0.70	2.09	1.39	4.87	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	0.00	4.43	6.64	0.00	0.00	0.00	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	0.00	3.24	0.00	0.00	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	17.44	0.87	0.00	0.87	1.74	3.49	0.00	2.62	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	0.00	4.50	2.25	0.00	0.00	0.00	13.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	3.48	3.48	0.00	0.00	0.00	3.48	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	1.07	0.00	3.20	2.13	3.20	0.00	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	24.94	1.39	0.00	2.77	0.00	2.77	0.00	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	2.85	2.85	0.00	0.00	0.00	0.00	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	18.41	0.00	0.00	0.92	1.84	0.92	0.00	1.84	0.92	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	0.00	0.00	0.00	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	2.11	3.17	0.00	0.00	3.17	0.00	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	3.51	0.73	2.04	1.71	0.57	1.22	0.73	0.73	0.33	0.49
Keratinocyte - epidermal, donor2	11349-117G8	0.00	1.17	1.76	0.59	0.59	0.59	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	2.27	1.04	0.76	0.57	0.19	1.23	1.70	0.28	0.19	0.76
Keratinocyte - oral, donor1	11251-116E9	3.75	1.02	8.63	0.68	1.02	1.70	1.14	1.25	0.23	0.68
Keratocytes, donor1	11527-119I6	6.53	9.28	2.06	7.56	2.41	3.09	0.34	3.78	5.85	2.06
Keratocytes, donor2	11607-120I5	1.17	1.17	1.17	2.34	1.17	2.34	0.00	2.34	0.00	7.03
Keratocytes, donor3	11688-122I5	2.37	1.98	0.99	3.36	1.78	1.78	0.20	1.78	0.99	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	32.97	0.00	21.98	2.20	10.99	15.39	8.79	28.57	2.20
Lens Epithelial Cells, donor1	11529-119I8	4.31	1.08	0.00	2.16	2.16	0.00	0.00	2.16	0.00	3.24
Lens Epithelial Cells, donor2	11609-120I7	6.46	2.65	1.38	1.50	1.96	0.35	2.19	0.92	0.23	1.04
Lens Epithelial Cells, donor3	11690-122I7	6.36	6.76	0.40	2.62	1.61	1.21	2.02	2.02	0.71	1.82
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.76	3.32	0.59	4.03	0.95	0.95	2.49	1.42	1.19	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.47	1.95	0.84	2.79	0.28	0.56	1.12	0.00	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.45	2.20	0.31	4.72	1.89	1.26	2.20	0.79	1.26	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.38	0.00	0.54	2.15	0.00	0.54	1.08	0.54	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	2.21	0.63	5.36	1.89	1.26	1.58	1.26	0.63	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	4.64	1.40	0.97	5.50	1.40	0.97	1.83	1.08	0.97	2.59
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	0.41	1.23	3.28	1.23	0.41	0.82	1.23	1.23	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.54	2.78	0.51	3.54	1.01	0.25	0.51	0.76	0.25	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.07	2.96	0.28	4.79	0.99	1.55	1.83	1.55	1.13	2.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.96	3.16	0.79	2.37	0.40	1.19	0.40	0.79	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.27	1.36	0.78	5.04	1.55	1.55	1.16	1.16	0.78	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.07	2.41	0.74	5.37	1.67	0.74	2.04	0.56	0.56	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4.53	2.09	1.05	2.09	1.39	0.00	1.39	1.74	0.00	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	3.82	2.15	0.48	4.29	0.48	0.48	0.95	0.48	0.72	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.08	3.85	0.82	4.94	1.92	1.65	1.65	1.24	0.96	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	1.54	1.54	4.31	0.92	0.31	0.92	0.92	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.18	0.94	0.94	2.18	0.62	0.00	0.62	0.94	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.95	3.29	0.73	5.31	1.28	1.46	2.01	0.91	1.28	2.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	1.32	0.99	3.29	1.97	0.33	0.66	0.99	0.33	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	0.88	0.59	2.93	0.88	1.46	0.59	1.46	0.59	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.73	2.49	0.50	5.97	1.24	1.00	1.74	0.75	0.75	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	5.33	2.42	0.00	0.97	0.48	0.48	1.45	0.00	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.50	2.15	0.54	4.58	1.62	0.81	0.54	0.81	0.27	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.60	2.42	0.61	4.39	1.36	0.91	1.82	0.61	1.51	1.82
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.70	1.04	0.00	0.52	0.00	0.52	0.52	0.52	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	2.51	1.05	0.63	2.72	0.63	1.05	0.21	1.26	0.63	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.21	3.31	0.75	4.81	1.35	1.80	2.56	0.60	1.20	1.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	1.38	0.69	2.06	0.69	0.00	1.38	0.00	0.69	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.01	3.01	0.00	3.95	0.94	2.26	1.13	0.19	0.56	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.56	2.33	0.95	5.83	1.27	1.17	1.70	0.53	1.38	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	4.36	0.48	0.00	3.39	2.42	1.94	1.45	0.97	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.32	2.32	2.65	2.98	0.66	0.99	0.00	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	5.95	2.60	0.99	6.57	2.35	1.73	1.12	0.62	0.87	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.74	2.96	1.85	2.59	1.11	1.11	1.48	0.37	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2.22	1.24	0.25	1.98	0.49	0.25	0.49	0.25	0.49	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.12	4.81	0.82	4.12	1.79	1.24	2.47	0.27	1.65	2.34
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	4.82	1.61	0.64	3.86	0.64	0.32	3.22	0.64	1.61	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	4.26	3.65	0.91	3.35	1.52	1.83	0.91	1.22	1.22	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.88	3.08	0.56	5.32	1.82	1.26	1.54	0.00	0.84	1.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.40	1.78	0.71	2.84	1.07	1.78	0.71	1.07	0.71	2.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	0.97	1.45	1.45	3.88	0.00	0.48	0.48	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.96	2.18	0.31	4.98	0.93	2.02	2.18	0.62	0.62	2.18
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	2.15	0.72	0.00	2.51	0.36	0.36	0.72	1.43	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3.27	1.96	0.65	3.27	0.98	1.63	0.98	1.31	0.98	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.24	1.41	0.24	7.30	2.59	1.41	0.71	1.18	0.71	2.35
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.94	1.49	0.74	5.57	1.24	0.87	1.73	1.49	2.60	2.48
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.56	1.79	0.77	1.79	0.51	0.77	0.00	0.00	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.97	2.39	0.60	4.48	1.19	1.19	1.79	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	20.39	0.00	0.00	0.00	4.53	2.27	0.00	2.27	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.81	6.14	3.07	0.00	1.53	2.30	3.07	0.00	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	6.68	0.74	0.74	0.00	2.23	0.74	2.23	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.66	8.89	0.42	0.00	0.00	5.08	0.85	0.85	4.23	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	7.03	0.00	0.70	0.00	1.41	0.00	1.41	3.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	12.14	0.93	0.93	0.00	1.87	0.00	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	11.34	7.21	0.52	0.52	0.52	1.55	0.00	1.03	2.58	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	10.71	1.19	0.00	0.00	2.38	1.19	1.19	4.76	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.88	9.05	0.90	0.45	0.90	3.39	0.90	0.90	1.36	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.72	8.43	0.29	0.58	0.29	3.20	0.29	0.58	1.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.45	4.95	0.45	0.45	0.00	2.70	0.00	0.90	2.25	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.30	14.63	0.68	1.90	1.08	3.25	1.22	0.81	6.23	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.89	12.32	0.00	0.00	1.03	4.11	0.00	2.05	3.59	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.47	7.06	0.71	0.00	1.06	3.18	0.35	1.41	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.66	2.00	0.00	0.00	0.67	2.00	0.67	0.67	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	17.32	12.23	1.02	0.51	1.53	2.04	1.02	0.00	2.55	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	8.80	9.07	0.00	0.53	0.00	3.20	1.07	0.80	4.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.47	10.20	0.94	0.57	1.13	2.27	0.76	0.57	3.40	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.73	9.20	0.61	0.00	0.61	4.91	1.23	1.84	3.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	21.20	8.97	0.00	0.00	0.82	4.08	0.00	1.63	6.52	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	8.33	9.16	0.62	0.62	0.42	3.75	0.83	1.25	4.37	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.29	8.13	0.56	0.84	0.28	3.08	0.56	0.56	3.64	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	22.67	12.36	1.03	1.03	0.00	2.06	1.03	2.06	5.15	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	10.74	7.26	1.45	0.58	0.58	2.61	0.87	1.16	2.61	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	7.47	8.97	0.30	0.60	0.00	1.49	0.30	2.39	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	6.64	6.09	0.00	0.55	1.11	3.32	0.55	0.00	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.26	9.19	0.71	2.47	2.12	4.24	2.12	1.77	1.77	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.38	10.33	0.37	1.48	0.37	3.32	1.48	0.74	2.58	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	3.45	1.15	0.00	1.15	3.45	0.00	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	8.44	0.38	0.38	0.38	4.61	2.30	0.77	3.45	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	12.45	10.76	1.13	1.13	0.00	6.23	2.26	2.26	3.40	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	4.92	0.00	0.00	0.00	3.28	0.82	1.64	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.36	10.39	0.45	0.90	0.90	4.52	2.71	2.26	4.07	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	10.77	0.00	2.87	0.00	1.44	1.44	0.00	3.59	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	10.46	7.47	0.00	1.49	2.24	2.99	2.24	0.75	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.03	7.43	0.37	1.11	0.37	3.72	1.11	1.11	7.06	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.49	7.32	0.43	0.86	1.29	5.60	0.86	0.43	2.15	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	8.56	11.99	0.00	0.86	0.86	1.71	2.57	1.71	4.28	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.99	10.33	1.00	1.33	0.33	4.00	1.00	1.33	4.66	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.86	11.46	1.21	1.21	0.00	3.02	1.21	1.21	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	6.40	1.42	1.42	0.71	3.55	0.71	1.42	4.98	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.37	9.62	0.34	1.03	1.03	2.75	1.72	1.37	2.41	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.96	7.51	0.54	0.00	1.07	3.22	0.54	1.07	4.29	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.81	9.43	0.00	0.00	0.67	5.39	1.35	3.37	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	16.67	9.63	0.37	1.11	1.11	3.70	2.96	1.85	4.07	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1.16	6.98	0.00	0.00	0.00	4.65	0.00	0.00	6.98	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	13.75	9.52	0.00	1.06	0.00	1.06	2.12	4.23	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.01	9.60	0.80	0.40	1.60	1.20	0.40	1.20	3.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	11.63	13.08	2.18	0.73	0.73	4.36	2.18	2.18	5.81	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	16.10	0.00	0.77	0.00	3.83	1.53	3.07	3.83	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	10.85	1.48	1.97	1.97	5.43	0.99	1.97	3.45	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	21.64	1.88	0.00	0.00	2.82	0.00	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.07	12.57	0.50	0.50	0.50	5.03	0.00	1.51	3.02	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	9.46	0.90	0.45	0.90	5.41	0.90	4.96	3.15	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	5.16	1.72	3.44	0.00	3.44	0.00	3.44	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	17.81	10.24	0.89	0.89	1.34	3.56	0.89	2.23	3.12	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	13.29	12.90	0.39	1.17	1.17	5.87	0.78	1.56	7.04	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.24	9.90	0.66	0.00	0.66	4.62	0.00	1.32	3.30	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	15.05	11.42	0.00	1.04	1.04	4.15	1.56	1.04	4.15	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	11.38	14.00	0.88	2.19	2.19	6.13	1.75	0.00	5.25	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	7.27	1.68	0.00	0.00	5.03	0.00	2.80	2.80	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.37	8.39	0.44	0.44	1.32	3.53	1.32	0.88	3.09	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.04	13.50	1.16	0.39	0.77	5.01	1.16	1.54	3.09	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.14	9.62	0.51	0.00	0.51	4.05	1.52	2.03	2.03	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.05	5.77	0.00	2.40	0.00	3.84	1.92	2.40	4.33	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.31	7.95	0.40	0.00	1.99	5.17	0.80	2.78	4.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	7.90	0.61	0.61	0.00	2.43	1.22	2.43	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	3.46	0.00	0.69	0.00	2.77	0.00	0.00	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	16.72	9.12	0.00	0.38	0.38	1.90	1.90	0.38	5.32	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	16.01	7.75	0.52	0.52	0.00	3.10	1.03	2.07	3.10	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	7.26	6.65	0.00	0.60	0.00	6.65	1.81	2.42	1.81	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.53	5.70	0.95	1.27	1.27	3.17	1.58	2.54	3.17	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.26	9.06	0.00	0.53	0.00	2.67	1.60	1.07	5.33	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	3.45	0.00	1.15	0.00	2.30	0.57	2.30	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	10.28	0.51	0.51	1.03	4.11	2.06	4.63	3.60	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	3.54	0.00	0.00	0.71	2.12	0.00	1.41	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.19	4.54	0.00	0.00	0.00	2.27	0.57	1.70	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	20.39	5.82	0.42	0.00	1.25	3.33	4.58	2.08	4.58	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	7.05	0.78	1.57	0.00	4.70	1.57	0.00	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.02	1.67	0.84	0.84	0.42	2.09	1.25	2.09	2.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.62	3.72	0.46	0.46	0.93	3.72	1.86	1.39	3.25	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	2.01	0.67	1.34	0.67	2.68	0.67	0.67	2.68	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.95	2.67	0.00	1.07	0.53	2.67	1.07	1.60	2.14	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	3.64	4.04	0.81	2.83	0.00	2.83	2.02	1.21	3.64	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	5.51	0.92	0.92	0.92	2.75	0.00	1.84	3.67	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	6.22	0.89	2.67	0.89	0.00	0.00	1.78	2.67	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.11	8.55	0.57	0.57	1.14	2.28	3.42	2.28	4.56	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	11.50	6.90	0.00	0.77	0.77	1.53	1.53	3.83	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	10.94	3.83	0.00	2.19	0.55	1.09	0.00	0.55	1.64	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.93	4.45	0.45	0.89	0.45	2.23	1.78	4.01	2.23	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	9.88	11.70	0.52	0.52	1.30	3.12	1.30	1.56	2.08	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	5.97	1.33	0.66	0.66	1.33	0.66	2.65	2.65	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	10.39	0.00	0.00	4.16	8.31	0.00	4.16	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	7.29	0.68	3.42	2.73	1.37	1.14	2.73	2.96	2.28	2.51
Macrophage - monocyte derived, donor2	11313-117C8	1.84	0.92	2.02	0.00	0.00	0.37	0.18	1.10	1.65	0.18
Macrophage - monocyte derived, donor3	11389-118C3	2.75	0.92	1.70	1.70	0.79	0.92	0.26	1.05	2.88	1.44
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1.59	0.53	1.59	0.00	0.00	0.00	0.53	0.00	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	2.38	0.16	1.58	0.95	0.32	0.48	1.27	0.00	0.63	0.79
Mallassez-derived cells, donor3	11930-125I4	1.25	0.28	1.53	0.14	0.42	0.69	1.39	0.28	0.28	0.69
Mammary Epithelial Cell, donor1	11273-116H4	1.79	2.29	3.59	0.50	0.50	1.10	0.10	0.50	0.90	0.20
Mammary Epithelial Cell, donor2	11350-117G9	2.90	2.03	2.90	0.87	0.58	1.74	0.00	0.87	0.58	1.16
Mammary Epithelial Cell, donor3	11422-118F9	2.24	1.00	1.75	1.00	1.25	0.75	1.00	0.25	1.00	0.25
Mast cell - stimulated, donor1	11487-119E2	5.42	72.54	15.59	3.39	2.03	22.37	0.68	0.68	31.86	2.03
Mast cell, donor1	11563-120D6	9.73	10.92	5.19	1.08	1.62	5.41	1.84	0.76	2.81	4.00
Mast cell, donor2	11565-120D8	19.32	33.58	43.09	11.89	9.81	23.18	13.37	2.08	16.05	22.29
Mast cell, donor3	11566-120D9	21.84	33.99	62.36	17.56	10.36	18.24	16.88	4.50	19.81	24.31
Mast cell, donor4	11567-120E1	14.54	26.24	38.83	10.11	9.93	17.37	13.12	2.66	19.86	28.01
Mast cell, expanded and stimulated, donor5	11940-126A5	6.88	18.63	8.65	5.32	3.99	4.55	8.54	2.33	12.31	9.65
Mast cell, expanded and stimulated, donor8	11942-126A7	8.76	9.34	8.17	5.25	1.17	2.33	2.33	0.00	4.67	1.75
Mast cell, expanded, donor5	11939-126A4	4.13	5.74	7.80	1.95	1.61	2.52	2.41	1.26	3.44	5.05
Mast cell, expanded, donor8	11941-126A6	12.22	5.52	15.90	3.01	2.18	3.18	4.69	2.18	2.18	6.36
Melanocyte - dark, donor1	11502-119F8	4.38	1.49	0.30	3.98	0.80	0.60	2.19	0.40	0.20	0.90
Melanocyte - dark, donor2	11582-120F7	8.65	1.38	0.35	5.19	1.73	0.00	1.04	0.69	0.35	2.08
Melanocyte - dark, donor3	11663-122F7	5.87	3.04	0.65	0.36	1.88	1.96	0.51	1.16	1.23	0.58
Melanocyte - light, donor1	11274-116H5	10.58	6.58	0.94	0.47	0.47	2.35	0.24	0.71	1.41	0.24
Melanocyte - light, donor2	11351-117H1	16.38	0.68	1.36	0.00	2.05	0.68	2.05	2.05	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	1.73	0.87	2.60	0.87	0.87	0.00	1.73	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	4.58	1.56	0.31	1.04	2.08	1.98	1.15	0.83	0.21	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	6.19	1.34	0.27	1.08	1.34	1.08	1.08	0.00	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	14.20	0.27	0.80	0.54	2.41	1.61	0.80	1.61	0.00	0.27
Meningeal Cells, donor1	11493-119E8	7.94	7.44	4.22	7.94	4.09	1.86	3.47	1.61	2.23	5.33
Meningeal Cells, donor2	11573-120E7	10.56	7.04	2.20	5.72	3.96	1.32	0.88	1.32	0.88	3.96
Meningeal Cells, donor3	11654-122E7	2.77	3.99	1.47	3.26	2.36	0.82	1.22	0.49	0.57	2.20
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	0.86	1.14	2.00	4.28	2.57	0.29	2.00	0.29	0.29	2.28
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	4.83	10.16	0.30	3.72	1.01	2.42	1.11	0.70	3.12	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	3.94	15.77	1.31	0.00	5.26	1.31	0.00	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	3.92	18.31	3.92	0.00	3.92	1.31	3.92	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	0.72	0.72	0.00	0.72	2.15	0.72	2.87	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	4.66	4.87	0.85	3.18	1.48	1.06	1.06	1.91	1.06	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	4.02	1.01	1.01	2.01	0.50	1.01	1.51	0.50	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	2.20	2.64	2.20	8.57	2.86	1.32	6.81	1.54	0.44	3.52
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	2.19	1.46	13.88	7.31	2.19	3.65	1.46	0.00	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	3.07	1.84	1.23	5.12	2.86	0.82	3.27	1.23	0.61	3.27
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	1.39	0.69	2.91	2.22	1.25	0.55	0.55	0.69	0.28	1.52
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.60	2.23	2.23	17.47	7.43	0.74	3.72	1.12	2.97	6.69
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	2.24	2.89	2.37	7.76	3.68	0.26	1.84	0.66	1.84	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.67	0.30	1.48	5.93	4.15	0.30	0.89	1.48	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	9.34	0.00	2.34	2.34	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.84	3.84	2.56	3.20	1.92	0.64	1.28	0.64	0.64	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	0.35	3.54	1.06	1.06	0.00	1.42	0.35	0.35	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	0.31	2.81	0.94	5.94	1.25	0.63	2.81	1.25	0.94	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	0.73	2.18	0.00	0.00	0.00	2.18	0.00	0.00	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	1.86	0.80	2.12	3.71	1.59	0.00	2.12	1.33	0.53	1.06
Mesothelial Cells, donor2	12156-128G5	2.00	0.50	1.50	3.50	0.00	0.50	1.50	0.50	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	3.18	1.30	0.79	3.18	0.94	0.65	3.25	0.87	0.79	2.31
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	5.40	0.00	4.05	1.35	1.35	1.35	1.35	8.10	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	5.91	1.97	0.99	0.99	0.00	1.48	0.99	1.23	1.48	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.94	1.18	2.06	0.88	0.00	1.18	0.59	0.59	1.18	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00	3.46	0.00	0.00	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	3.41	0.62	0.93	0.93	0.00	0.00	0.62	0.31	1.24	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	2.07	1.24	1.24	0.62	0.21	0.83	0.21	0.62	0.41	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	0.00	0.00	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	4.50	0.25	1.00	1.00	0.75	0.75	1.00	1.50	0.75	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	3.72	1.40	0.47	1.40	0.47	1.40	0.47	0.47	0.93	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.66	0.81	1.02	1.02	0.00	0.00	0.61	1.42	1.02	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.17	1.58	0.00	0.00	0.40	1.19	0.79	0.79	0.40	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	8.55	0.00	8.55	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	0.88	1.77	0.00	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	1.14	0.76	1.14	0.38	0.00	0.38	0.38	0.76	0.00	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	2.63	0.00	0.00	3.95	2.63	0.00	2.63	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.61	0.42	0.42	0.64	0.42	0.21	0.21	1.27	1.27	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.28	0.30	0.30	0.60	0.00	0.30	0.89	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	5.03	0.00	1.68	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1.00	0.50	0.75	0.50	0.00	0.50	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	1.66	1.43	0.24	0.95	0.24	0.95	0.00	0.95	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.11	0.55	0.00	1.66	0.00	0.55	0.55	0.00	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1.15	0.92	0.00	1.15	0.00	0.00	0.69	0.00	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.26	1.26	0.63	1.05	0.21	0.21	0.63	1.26	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.63	0.00	0.20	1.43	0.41	0.41	0.82	1.02	0.00	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1.72	0.21	0.21	0.64	0.00	0.43	0.64	0.21	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.00	0.67	0.44	0.89	0.44	0.00	0.89	0.22	0.44	1.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.10	0.22	0.00	1.10	0.44	0.00	0.88	0.00	0.66	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1.52	0.51	0.00	2.53	0.51	0.00	0.51	1.52	1.01	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	3.31	1.66	0.00	0.00	0.00	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1.09	0.00	0.00	1.63	0.00	0.00	0.27	0.27	0.54	1.90
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.59	0.29	0.29	2.94	0.29	0.00	1.47	0.00	0.00	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	2.18	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	0.00	0.00	1.44	0.00	0.00	0.00	0.00	0.00	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.80	0.00	0.80	4.00	0.00	0.40	0.40	0.00	0.80	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	0.00	0.00	0.00	1.37	1.37	1.37	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1.00	0.50	0.00	2.00	0.00	0.00	1.50	0.00	0.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	4.08	2.04	0.00	4.08	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.31	0.00	0.00	1.31	0.44	0.00	1.75	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	0.00	0.00	4.41	0.00	0.00	1.10	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1.28	0.64	0.00	1.28	0.00	0.00	3.84	1.92	0.64	3.20
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.25	0.00	0.00	1.98	0.99	0.00	2.98	0.00	0.25	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	0.00	0.00	2.09	0.70	0.00	3.48	0.00	0.00	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	2.21	0.00	0.00	0.00	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	1.03	0.00	0.00	1.71	1.71	0.00	1.37	0.34	0.00	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.31	0.00	0.00	3.94	0.00	0.00	4.81	0.00	0.00	4.81
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.84	0.00	0.36	2.84	0.36	0.36	2.13	1.78	0.36	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.00	0.00	0.00	2.52	0.28	0.28	2.81	0.28	0.00	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	0.83	0.42	1.66	0.42	0.42	1.66	0.00	0.42	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.91	1.17	0.00	2.33	0.58	0.58	5.24	0.58	0.58	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.60	0.60	0.60	4.83	1.51	0.00	1.81	0.60	0.30	3.32
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.83	0.00	0.00	2.09	0.42	0.00	2.09	0.42	0.00	4.17
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1.85	0.92	1.85	0.92	0.92	0.00	2.77	0.00	0.92	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1.14	1.14	0.57	1.71	0.00	1.14	1.71	1.14	1.14	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2.21	0.28	0.69	3.32	1.38	0.41	1.93	0.83	0.28	3.59
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.33	0.00	1.30	1.81	0.00	0.00	3.11	0.00	0.00	1.81
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2.14	0.00	2.14	2.57	0.86	0.00	2.57	0.86	0.86	4.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	0.00	0.64	3.18	0.00	0.64	5.08	3.18	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.47	0.53	1.33	2.94	1.07	0.27	3.47	0.80	0.00	2.94
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2.39	0.90	2.39	1.20	0.90	1.20	1.20	0.90	0.30	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	2.12	0.71	0.85	1.55	1.13	0.00	1.98	0.71	0.57	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.64	0.32	0.64	2.87	0.96	0.32	2.55	0.64	0.64	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1.99	0.88	1.99	2.65	0.66	0.22	2.21	0.66	0.00	3.32
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	2.28	0.38	0.76	3.41	0.00	0.76	2.65	2.65	0.38	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2.56	0.28	3.41	3.41	0.28	0.00	2.56	0.57	0.00	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1.47	0.49	3.20	2.21	0.98	0.74	2.46	0.49	0.00	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	1.30	0.00	1.30	1.30	0.00	3.26	5.21	1.96	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1.76	0.29	2.94	2.65	1.18	0.29	3.53	1.18	0.88	2.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1.44	1.44	2.88	1.15	0.86	0.29	1.73	0.00	0.86	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.06	1.65	1.65	3.71	0.00	0.82	0.41	0.82	0.82	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.38	0.89	3.87	2.98	1.79	0.60	0.89	1.49	0.89	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	0.00	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.61	0.66	1.64	1.31	0.66	0.66	0.33	0.66	0.99	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1.05	0.00	0.00	2.10	0.00	0.00	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1.98	0.99	1.98	0.99	0.79	0.20	0.79	0.59	0.79	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.93	0.00	0.00	0.00	0.00	0.00	0.93	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.50	1.88	1.13	1.50	1.50	0.00	0.38	0.75	2.25	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.27	0.27	0.27	0.27	0.27	0.27	0.00	0.80	1.60	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.70	0.11	1.13	0.90	0.68	0.34	0.34	0.45	1.13	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	2.21	0.00	1.47	0.74	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2.20	1.10	2.20	1.10	0.00	0.37	0.37	1.10	0.73	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	0.53	0.00	0.00	1.07	0.53	0.00	0.53	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	0.00	1.01	2.02	0.00	1.01	2.02	1.01	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.84	0.84	0.42	0.84	0.00	0.42	0.42	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	1.36	4.09	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	3.81	0.00	0.00	0.00	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.81	0.00	0.81	0.00	0.81	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	0.00	4.53	1.51	0.00	0.00	0.00	0.00	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	0.00	0.00	11.42	0.00	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	6.52	3.26	0.00	0.00	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	12.55	12.55	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	3.23	0.43	0.86	2.80	2.80	1.08	1.08	0.65	1.08	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	2.09	1.05	0.52	0.52	0.52	0.52	1.57	1.05	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	0.67	2.00	0.67	2.00	2.67	1.33	0.00	2.67	0.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.09	2.50	0.42	2.92	0.42	1.25	0.83	2.50	0.83	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	3.42	1.90	1.52	0.38	1.52	1.14	2.09	3.42	0.95	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1.60	4.79	0.00	6.38	4.79	6.38	1.60	3.19	1.60	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	1.36	2.72	1.36	4.08	0.68	2.72	0.00	2.04	0.00	2.72
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	11.03	3.68	1.84	0.00	3.68	5.51	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	0.84	1.67	2.51	3.35	0.42	0.42	2.09	0.00	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	2.32	1.63	2.09	2.32	1.63	0.70	1.39	1.86	0.23	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	5.67	2.97	1.08	2.16	2.16	1.08	0.81	1.89	0.27	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	5.05	2.31	3.57	2.94	3.36	1.26	3.15	2.52	0.42	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	22.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.48	0.99	2.98	2.48	2.98	0.50	0.99	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	2.17	0.81	4.33	2.71	1.89	1.08	1.89	1.08	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.31	2.72	2.04	2.27	2.49	1.13	1.36	1.13	1.36	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.37	2.12	0.82	2.94	2.61	1.47	0.49	2.78	0.49	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	5.65	1.64	2.37	6.20	2.37	0.91	3.46	2.19	0.55	3.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	2.65	1.59	6.37	4.77	0.53	0.53	0.53	0.00	4.24
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	4.80	0.60	3.60	4.20	3.00	0.60	2.40	0.00	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.55	2.63	9.52	1.31	1.64	0.98	1.31	5.25	0.33	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.90	2.60	0.81	2.60	1.79	2.11	0.65	1.79	0.81	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	8.47	2.82	2.65	7.23	3.35	2.29	0.88	3.00	0.88	4.76
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	5.63	3.52	0.00	3.52	2.11	0.70	0.00	5.63	0.00	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.38	2.76	0.46	3.68	3.22	1.84	0.92	0.92	0.46	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.50	2.89	1.29	4.18	2.25	1.29	0.00	1.61	0.64	2.57
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	3.45	2.76	1.38	2.07	0.69	0.69	2.41	0.69	1.38	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	27.81	7.59	7.59	5.06	7.59	0.00	17.70	7.59	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	6.68	5.79	1.11	3.79	3.79	1.78	1.56	2.01	1.11	2.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.50	2.96	1.27	3.39	3.81	1.27	0.85	1.27	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.98	0.47	3.56	3.09	2.61	0.24	0.47	2.37	0.00	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.43	4.29	2.15	2.15	4.29	0.43	0.43	3.00	1.29	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	135.42	9.03	9.03	0.00	0.00	0.00	9.03	0.00	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	4.00	3.33	1.33	1.67	2.00	1.67	2.33	0.67	1.67	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	5.41	4.51	0.45	0.90	2.25	3.61	0.90	0.90	0.45	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.36	2.38	1.98	0.00	1.59	0.40	0.00	3.57	0.79	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	2.79	2.79	1.86	1.86	1.86	1.86	0.93	1.86	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.41	0.76	0.76	3.78	1.14	0.38	0.00	1.89	0.38	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	6.19	0.00	0.65	1.96	0.65	0.65	0.65	0.65	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	4.79	0.44	2.61	2.61	1.74	1.31	3.49	0.44	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	4.98	1.81	2.71	1.81	4.98	3.62	1.81	2.71	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	5.29	0.00	0.88	3.53	2.65	0.00	2.65	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	1.99	2.66	3.32	4.65	1.33	0.00	0.66	1.33	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	4.46	3.47	0.99	1.49	2.48	2.48	0.99	2.48	1.98	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.66	5.74	1.53	2.68	2.30	0.38	0.38	1.91	0.77	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.98	2.72	3.02	2.12	2.72	0.30	0.30	3.33	0.91	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	8.40	2.65	0.88	2.65	1.33	1.55	1.99	2.65	1.11	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	4.74	0.00	2.71	1.36	0.68	1.36	2.71	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	10.22	20.44	0.00	0.00	5.11	5.11	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.27	3.66	0.61	2.44	3.05	1.22	0.61	1.83	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.41	4.72	0.94	0.63	1.57	1.57	0.94	3.46	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	8.17	1.82	0.30	3.03	5.75	0.91	0.91	3.63	0.30	3.93
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	1.58	0.00	0.79	1.58	1.58	1.58	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	4.53	6.80	1.13	1.13	1.13	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	1.24	1.12	1.86	2.48	0.50	0.25	0.75	0.37	0.12	1.12
Myoblast, donor2	11322-117D8	3.07	2.69	1.15	4.41	3.07	0.77	2.11	0.77	0.77	2.11
Myoblast, donor3	11398-118D3	2.35	1.51	2.52	3.36	1.18	1.35	1.35	0.84	0.34	2.52
NK T cell leukemia cell line:KHYG-1	10777-110G3	17.66	10.07	0.00	1.61	1.46	2.92	2.19	1.75	1.46	2.77
Natural Killer Cells, donor1	11230-116C6	30.44	2.46	11.99	1.23	0.92	1.23	4.61	0.92	0.00	5.54
Natural Killer Cells, donor2	11311-117C6	32.87	1.81	7.54	1.81	3.62	3.32	2.41	2.41	0.00	3.92
Natural Killer Cells, donor3	11387-118C1	34.05	3.31	6.63	1.10	4.42	2.58	2.39	2.76	0.00	2.94
Neural stem cells, donor1	11275-116H6	17.06	14.15	4.72	11.25	11.61	2.90	1.09	3.99	2.18	6.17
Neural stem cells, donor2	11352-117H2	48.14	13.48	3.85	0.00	5.78	7.70	0.00	7.70	0.00	1.93
Neurons, donor1	11494-119E9	42.10	4.55	4.55	0.00	4.55	1.14	0.00	2.28	0.00	1.14
Neurons, donor2	11574-120E8	19.81	3.52	3.74	0.22	1.54	3.96	1.32	1.10	0.00	0.66
Neurons, donor3	11655-122E8	37.82	3.29	1.64	0.00	2.47	4.11	0.82	3.29	0.00	1.64
Neutrophils, donor1	11233-116C9	0.00	0.93	4.64	20.42	0.93	1.86	0.00	0.00	4.64	20.42
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	26.09	2.90	0.00	11.60	0.00	0.00	11.60
Neutrophils, donor3	11390-118C4	2.44	0.61	1.83	33.60	0.61	0.61	12.22	0.61	1.22	26.88
Nucleus Pulposus Cell, donor1	11252-116F1	2.37	0.83	4.87	6.89	3.80	0.12	1.31	0.83	0.36	3.21
Nucleus Pulposus Cell, donor2	11409-118E5	1.30	0.33	5.21	5.86	4.23	0.98	0.98	0.33	0.00	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	1.40	1.60	1.00	3.41	1.20	0.20	1.20	0.00	1.00	1.40
Olfactory epithelial cells, donor1	11933-125I7	2.34	1.10	0.96	2.20	2.20	0.41	1.38	1.38	0.14	1.79
Olfactory epithelial cells, donor2	11934-125I8	1.30	1.30	1.59	0.72	1.59	0.14	1.88	1.30	0.43	1.30
Olfactory epithelial cells, donor3	11935-125I9	2.16	1.02	2.50	1.25	1.25	0.45	0.68	1.59	0.45	0.68
Olfactory epithelial cells, donor4	11936-126A1	5.26	1.36	2.24	1.75	1.27	0.97	1.46	2.14	0.68	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	4.21	1.81	1.20	2.41	1.81	0.00	2.41	0.00	2.41	1.20
Osteoblast - differentiated, donor1	11276-116H7	2.13	1.91	2.55	3.19	2.98	0.21	1.06	0.64	1.28	1.28
Osteoblast - differentiated, donor2	11353-117H3	0.00	1.14	0.00	0.00	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	3.72	0.62	0.62	4.97	3.10	0.00	0.00	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	2.74	4.10	3.52	2.93	1.17	1.37	1.76	0.20	0.20	2.74
Osteoblast, donor2	11354-117H4	2.11	0.70	2.11	1.40	1.40	0.70	2.11	0.00	0.00	2.81
Osteoblast, donor3	11426-118G4	2.13	3.38	1.78	3.38	3.38	1.60	4.27	1.78	1.78	1.24
Pancreatic stromal cells, donor1	11249-116E7	1.68	1.60	4.38	1.52	1.18	0.34	0.84	0.67	0.59	1.10
Pericytes, donor1	11491-119E6	4.78	1.67	5.56	1.56	3.23	0.67	0.67	0.89	0.33	1.56
Pericytes, donor2	11571-120E5	7.47	1.58	4.30	2.72	4.53	0.68	0.23	2.72	1.36	1.36
Pericytes, donor3	11652-122E5	2.03	3.87	0.41	10.58	3.26	0.61	2.85	0.81	0.81	4.27
Perineurial Cells, donor1	11499-119F5	2.94	1.92	2.03	3.50	1.81	0.23	1.47	1.02	0.34	1.47
Perineurial Cells, donor2	11579-120F4	9.48	1.01	1.29	5.15	1.56	0.46	2.39	1.20	0.18	2.85
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	17.85	7.65	19.44	3.82	2.23	3.51	3.19	0.96	1.91	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.92	1.96	14.94	1.71	2.94	1.96	0.98	1.96	0.98	4.16
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.78	2.98	9.32	2.46	3.24	1.68	2.46	3.11	0.65	4.66
Placental Epithelial Cells, donor1	11278-116H9	2.15	0.48	0.96	2.15	2.39	0.24	3.35	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	0.00	0.00	1.11	3.33	2.22	1.11	2.22	0.00	0.00	2.22
Placental Epithelial Cells, donor3	11427-118G5	1.77	1.18	1.77	8.44	2.94	0.00	8.64	1.77	0.59	2.36
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	0.32	0.63	0.00	1.58	1.58	0.32	0.95	0.00	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	1.88	1.69	0.56	3.38	1.13	0.38	1.50	0.56	1.50	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.57	3.79	3.26	3.00	1.57	0.78	0.91	2.09	1.44	1.96
Preadipocyte - breast, donor2	11328-117E5	2.48	2.03	0.45	3.15	2.48	0.00	0.68	0.90	0.23	2.93
Preadipocyte - omental, donor1	11468-119C1	3.73	2.13	2.13	2.77	0.96	0.32	1.39	1.07	0.75	1.39
Preadipocyte - omental, donor2	11329-117E6	2.18	2.62	2.62	3.93	0.44	0.00	3.93	0.87	1.75	4.80
Preadipocyte - omental, donor3	11403-118D8	2.86	5.44	0.86	5.01	2.29	1.15	1.15	0.57	1.15	2.58
Preadipocyte - perirenal, donor1	11469-119C2	1.97	0.98	0.00	0.98	0.98	0.00	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	4.30	3.07	1.23	5.84	0.61	2.46	0.92	0.61	3.69	1.84
Preadipocyte - subcutaneous, donor2	11356-117H6	1.42	1.06	1.06	3.90	1.59	1.24	1.24	0.71	0.89	2.12
Preadipocyte - subcutaneous, donor3	11428-118G6	1.53	1.36	0.34	1.02	0.85	0.51	0.68	0.85	1.02	2.04
Preadipocyte - visceral, donor1	11280-116I2	1.77	2.24	2.42	3.26	1.21	1.68	1.86	0.93	2.33	2.14
Preadipocyte - visceral, donor2	11357-117H7	2.30	4.60	2.76	4.14	0.46	4.14	0.92	0.00	3.22	2.30
Preadipocyte - visceral, donor3	11429-118G7	1.15	0.94	1.25	2.09	0.63	0.10	1.15	0.00	1.67	1.78
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.37	6.79	0.91	1.96	1.66	1.51	2.11	0.60	1.51	0.15
Prostate Epithelial Cells, donor2	11331-117E8	3.52	0.68	0.81	1.35	0.95	0.68	1.76	1.22	0.68	0.95
Prostate Epithelial Cells, donor3	11404-118D9	3.12	1.41	2.57	1.47	0.49	0.86	0.67	1.59	0.80	0.12
Prostate Stromal Cells, donor1	11254-116F3	2.28	2.62	1.25	10.36	1.37	0.91	1.82	0.46	1.37	2.96
Prostate Stromal Cells, donor2	11332-117E9	1.43	5.02	1.79	14.88	3.77	1.79	4.12	0.54	0.54	5.38
Prostate Stromal Cells, donor3	11405-118E1	2.29	1.46	3.13	7.92	3.86	0.42	2.40	0.63	0.63	3.44
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.11	4.74	0.73	1.09	1.09	3.65	0.00	3.65	2.55	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	2.22	4.16	0.28	0.49	0.49	0.97	1.39	0.62	0.90	0.49
Renal Epithelial Cells, donor1	11517-119H5	4.57	6.09	0.51	3.04	0.00	3.55	6.59	4.06	5.58	2.03
Renal Epithelial Cells, donor2	11597-120H4	8.54	9.25	0.00	0.00	1.42	2.85	4.27	1.42	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	4.02	3.81	0.21	0.85	1.06	1.16	1.80	0.85	1.48	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.94	2.72	0.68	2.72	0.68	0.00	0.00	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.97	2.83	0.67	2.96	0.67	1.89	1.35	0.94	1.75	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.55	2.89	0.67	1.55	1.11	1.78	3.11	0.44	1.33	2.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.30	2.66	0.00	3.33	1.33	2.00	0.67	3.33	1.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	7.48	6.38	1.10	2.86	2.20	1.76	3.08	1.54	0.44	3.30
Renal Mesangial Cells, donor2	11598-120H5	7.52	3.13	1.25	2.51	1.25	0.63	1.25	2.51	1.25	1.88
Renal Mesangial Cells, donor3	11679-122H5	6.94	4.44	1.39	4.16	2.77	1.11	3.88	2.22	1.11	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	2.95	2.95	1.34	2.68	1.07	2.42	2.95	0.00	2.15	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1.27	2.53	0.42	0.84	0.84	2.11	2.11	0.84	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.52	5.21	1.16	2.89	1.93	2.12	2.51	1.54	0.96	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5.19	0.52	0.26	0.78	0.26	0.52	1.56	2.33	0.00	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.67	7.11	0.57	1.71	4.55	1.42	4.55	1.14	0.85	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	3.09	1.03	4.12	1.03	1.03	5.15	4.12	0.00	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	2.01	1.00	1.25	0.00	1.76	0.50	0.75	0.25	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	10.82	7.22	4.81	9.89	4.41	1.87	2.94	1.47	6.68	1.87
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.08	2.68	6.25	1.79	0.89	4.47	0.89	3.57	4.47	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	35.77	7.15	21.46	0.00	0.55	2.75	0.55	4.40	1.65	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.12	13.92	8.12	0.58	1.16	5.22	1.74	3.48	5.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	23.53	15.47	4.29	1.30	0.65	3.77	0.78	2.99	5.98	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.13	13.80	3.38	2.09	1.19	3.18	0.89	4.67	2.88	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	33.35	19.52	6.02	2.01	1.12	4.35	1.00	4.68	4.24	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	26.55	14.51	3.72	2.60	0.87	3.97	1.24	3.10	3.72	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.43	11.77	1.63	1.86	0.82	3.61	0.93	4.08	2.91	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	45.07	15.72	3.93	3.24	3.24	5.32	2.31	5.55	4.16	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	27.93	9.45	3.15	0.96	1.10	3.70	0.96	3.56	2.88	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	21.33	12.10	2.72	1.82	1.06	3.48	1.51	4.39	3.78	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	26.88	18.28	3.94	1.97	0.72	5.91	1.79	3.94	2.69	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	29.12	10.19	4.02	1.15	0.57	2.73	0.29	3.44	4.30	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.03	9.98	3.43	2.04	1.50	3.11	0.97	2.68	3.33	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.43	12.39	3.32	2.66	1.11	3.98	1.11	6.20	3.32	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	35.75	10.13	3.63	0.19	0.19	3.44	1.15	4.21	3.06	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	26.37	16.21	2.52	1.58	1.21	3.26	0.56	5.40	3.17	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	39.65	26.68	7.70	2.82	0.94	4.13	2.07	4.70	4.70	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	36.10	16.85	2.26	1.59	0.93	4.51	0.93	5.18	4.38	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.39	17.33	2.92	1.65	1.36	4.19	1.56	4.77	3.80	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	30.94	21.39	3.82	1.72	0.19	2.67	1.34	5.35	3.25	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	27.45	12.07	2.14	1.28	0.85	3.10	0.53	4.38	2.56	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	24.95	12.89	2.52	0.00	1.12	4.20	0.28	4.48	3.64	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	32.30	23.58	4.10	1.37	1.03	3.59	0.68	3.76	4.44	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	34.46	9.66	2.19	1.82	0.36	3.65	0.18	5.47	2.73	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.99	12.14	4.05	2.45	1.10	2.45	1.23	3.68	2.45	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	21.36	15.04	4.57	2.55	0.94	3.76	1.34	3.76	4.70	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	26.18	5.43	3.77	0.94	0.71	1.18	0.71	3.30	2.59	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.41	15.08	1.59	1.59	1.19	3.17	1.79	2.58	2.58	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.06	14.50	5.85	0.94	1.17	3.98	1.17	4.68	5.14	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.11	8.92	3.11	2.90	1.24	2.70	0.62	4.77	2.90	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	21.24	16.15	5.09	2.65	1.77	4.20	0.88	2.43	2.43	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	37.39	19.22	2.92	1.04	2.09	5.43	1.67	5.43	5.22	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	26.11	10.09	4.17	1.35	0.81	3.23	1.21	2.96	3.50	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	32.70	19.58	2.55	1.36	1.70	5.62	1.02	5.96	4.26	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	33.74	20.82	3.86	2.31	2.51	5.98	1.35	8.29	5.98	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.79	5.50	5.85	1.55	0.34	2.41	1.03	3.44	3.95	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	31.00	13.03	1.92	2.19	1.37	3.70	1.51	6.58	3.15	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	34.31	15.43	4.76	2.96	2.13	5.58	2.13	5.91	3.45	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	35.11	6.99	3.58	2.05	0.51	2.05	1.02	2.73	3.41	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.39	11.69	3.26	2.37	1.33	2.96	1.63	2.66	2.07	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.71	18.93	3.47	3.47	1.07	3.73	1.33	9.06	5.06	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	33.46	10.51	4.56	1.94	0.69	1.80	0.14	5.81	4.42	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.43	6.90	1.19	2.14	0.95	2.38	1.19	5.48	1.67	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	56.63	22.98	6.65	3.22	2.42	4.84	1.61	10.08	4.64	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	20.15	7.53	4.52	1.98	0.66	2.73	0.57	2.92	3.86	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.01	13.97	6.29	1.75	1.40	5.24	0.35	6.64	3.14	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.85	14.51	6.04	1.21	1.51	1.81	1.21	5.44	3.93	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	18.60	6.00	5.02	2.08	0.73	0.98	0.73	2.81	2.94	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	83.98	35.66	26.35	3.06	2.18	9.17	1.46	15.43	14.70	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	34.07	11.56	7.91	1.83	1.22	2.43	0.61	2.43	3.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.37	4.82	3.01	0.90	0.00	2.71	0.30	2.71	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	22.85	9.50	7.24	2.49	1.13	1.81	1.13	3.62	3.62	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	33.85	11.68	10.48	2.70	1.80	4.19	1.20	5.09	3.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	13.81	7.79	9.45	1.89	0.47	2.60	0.35	2.01	2.60	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.69	8.32	6.40	1.92	1.49	3.84	0.64	5.12	2.35	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	37.26	13.82	10.22	4.21	1.20	3.00	1.80	5.41	4.81	0.00
Schwann Cells, donor1	11498-119F4	3.20	5.64	1.88	4.14	3.20	2.63	2.44	2.44	2.63	3.95
Schwann Cells, donor2	11578-120F3	0.00	3.40	0.00	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	3.07	1.53	1.97	2.85	1.53	0.22	2.19	0.44	0.66	1.10
Sebocyte, donor1	11220-116B5	2.74	3.29	4.93	2.74	1.64	2.19	5.48	1.64	2.19	3.29
Sebocyte, donor2	11301-117B5	5.97	0.46	2.30	0.46	0.92	0.92	1.84	0.92	0.00	0.46
Sebocyte, donor3	11378-118B1	4.12	1.03	2.68	0.62	1.65	0.82	0.62	0.62	0.82	2.27
Sertoli Cells, donor1	11255-116F4	3.31	4.97	0.00	1.66	0.00	0.00	1.66	0.00	0.00	3.31
Sertoli Cells, donor2	11333-117F1	8.47	5.65	5.65	0.00	0.00	2.82	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	2.90	5.19	2.99	1.23	1.06	3.08	0.26	1.14	0.97	0.70
Skeletal Muscle Cells, donor2	11358-117H8	3.61	3.61	1.45	2.89	0.72	0.00	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	5.02	3.34	5.85	2.51	2.51	3.34	1.67	0.84	4.18	1.67
Skeletal Muscle Cells, donor4	11451-119A2	3.93	1.89	0.94	4.40	2.51	1.89	2.36	2.67	0.47	3.61
Skeletal Muscle Cells, donor5	11455-119A6	4.91	1.78	1.49	3.86	1.49	0.74	2.38	0.89	1.64	2.68
Skeletal Muscle Cells, donor6	11459-119B1	4.92	3.23	1.08	3.39	1.08	2.62	1.85	1.23	2.00	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	3.53	2.77	8.57	5.04	3.53	1.51	2.77	2.14	1.64	4.03
Skeletal Muscle Satellite Cells, donor2	11321-117D7	5.56	2.14	4.99	4.42	4.00	1.57	1.00	2.57	1.43	2.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	4.27	3.57	1.39	4.17	2.08	2.38	3.37	2.78	1.29	2.78
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.32	3.96	2.78	3.54	1.18	1.69	1.52	1.10	0.51	1.18
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	4.34	1.45	1.45	0.00	2.90	0.72	0.72	1.45	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	2.89	2.06	2.48	0.28	1.51	1.10	0.83	1.38	0.41	0.83
Skin - palm, donor1	10286-104F7	29.55	2.69	5.37	5.37	13.43	0.00	0.00	10.74	5.37	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	1.59	0.72	0.43	0.58	0.00	0.14	1.15	0.58	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	28.63	8.18	12.27	0.00	0.82	4.09	9.81	8.18	8.18	7.36
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	2.60	0.39	1.30	0.26	0.26	0.65	1.17	0.91	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	1.11	1.11	1.95	0.42	0.14	0.56	0.70	0.28	0.42	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	3.09	1.69	0.70	0.28	0.14	0.56	1.69	0.70	1.55	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	32.14	11.63	9.73	0.85	0.85	4.65	3.81	10.36	9.73	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	2.62	1.27	1.57	0.67	0.45	0.52	0.45	1.42	1.35	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.54	0.31	0.00	2.47	0.93	0.00	0.00	0.62	1.23	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	5.78	4.22	1.78	2.67	0.89	2.22	0.22	1.11	3.33	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	1.76	2.94	1.18	1.18	0.00	0.00	1.18	0.59	0.00	2.35
Smooth Muscle Cells - Aortic, donor1	11283-116I5	3.31	3.31	1.99	3.76	2.65	1.77	0.88	0.66	1.55	1.99
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.54	7.88	1.18	3.15	1.18	2.76	2.36	0.39	3.15	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	3.86	6.18	0.77	2.32	0.00	4.64	0.00	0.00	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	0.00	5.00	2.00	10.01	0.00	0.00	2.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	2.79	2.53	0.80	1.20	1.06	0.53	1.06	0.67	0.93	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	2.66	2.88	0.44	2.88	1.55	0.22	0.66	0.66	1.55	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	2.18	4.74	0.26	0.77	0.38	1.79	0.00	0.38	1.54	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	3.26	1.95	3.58	1.63	0.33	1.30	0.33	0.65	0.65	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	2.07	3.25	2.07	3.84	3.25	0.59	1.48	1.18	1.77	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	3.27	2.42	1.00	2.99	1.85	1.42	2.56	1.42	1.42	3.13
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.79	2.28	1.95	7.65	3.74	1.46	2.11	0.33	2.11	2.28
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	3.65	0.91	2.74	2.44	1.52	1.22	1.22	0.91	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.04	3.79	3.03	5.30	2.27	1.01	3.28	0.25	2.53	3.03
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00	12.24	12.24	6.12	6.12	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	2.38	1.91	0.95	0.95	0.00	0.95	0.00	1.43	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	2.06	3.69	1.03	1.92	0.59	1.47	1.47	0.44	1.18	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	3.87	4.95	1.72	4.74	0.65	2.58	1.29	1.72	3.01	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	4.93	4.72	0.31	5.25	1.47	1.47	3.36	1.78	0.84	2.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	2.78	10.05	0.62	3.40	1.70	3.09	1.86	0.77	3.40	1.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	0.00	6.47	1.08	2.16	0.00	1.08	0.00	0.00	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	1.49	5.38	0.30	1.79	0.60	1.20	0.90	0.90	1.20	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.76	3.76	3.07	8.19	1.71	2.05	4.78	1.02	1.02	3.41
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	2.75	1.96	4.40	4.08	2.67	0.86	1.41	0.86	0.86	1.96
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1.01	2.52	1.11	2.42	1.51	0.60	1.01	0.81	1.11	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	6.83	1.82	1.37	6.83	2.28	0.23	2.05	0.91	0.46	4.32
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	0.60	0.00	0.60	0.00	0.60	0.60	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	2.65	3.97	0.53	6.36	2.38	1.85	4.50	1.06	0.26	3.18
Smooth Muscle Cells - Prostate, donor1	11257-116F6	2.53	3.20	2.80	7.72	1.20	1.46	2.00	0.80	2.00	4.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	4.26	3.63	1.75	9.02	3.51	2.88	2.50	1.00	1.75	3.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	1.01	0.25	2.03	2.79	1.52	0.25	0.51	0.51	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	3.32	2.56	1.36	5.28	1.81	1.21	1.81	1.36	1.81	2.71
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	0.00	0.75	2.25	2.25	0.00	3.00	0.75	0.75	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	6.46	7.75	5.17	7.75	2.58	1.29	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.05	6.51	1.86	2.79	0.93	2.79	3.26	3.72	0.47	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	4.54	4.54	0.00	1.51	0.50	0.50	1.01	1.51	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.89	2.19	0.63	2.19	1.88	0.94	0.94	0.94	0.94	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	0.59	3.83	4.72	2.36	0.00	1.47	0.29	0.00	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1.00	3.08	1.58	3.75	1.75	1.33	2.08	0.67	2.00	2.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	3.27	0.93	1.40	6.07	3.74	0.47	0.93	0.93	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.32	6.19	0.00	2.30	1.15	1.44	1.01	0.58	1.44	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	2.29	3.82	1.02	1.53	0.51	1.02	1.02	0.76	0.51	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.01	2.82	0.00	1.32	0.75	2.26	0.56	0.56	1.13	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	2.38	2.66	0.98	2.38	0.98	1.12	2.10	0.84	0.70	2.24
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	0.59	1.68	0.34	2.01	0.92	0.50	0.75	0.42	0.34	1.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	1.43	0.00	3.81	2.86	0.95	1.90	0.00	0.95	2.38
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.65	4.16	0.00	0.73	0.98	0.98	2.20	0.73	0.73	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	4.64	2.87	1.10	6.85	0.88	0.66	3.54	0.22	1.77	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	2.63	0.88	2.34	2.05	0.88	0.00	1.46	0.59	2.93	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.22	0.19	1.36	2.53	0.78	0.39	1.17	1.75	0.00	1.36
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	0.79	0.79	1.06	2.91	2.91	0.26	1.06	0.79	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.60	0.37	3.35	2.23	1.86	0.00	0.00	0.74	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	4.67	0.72	1.44	3.59	1.08	0.36	1.80	1.08	0.36	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.27	2.84	0.28	3.12	1.42	0.85	0.85	0.85	1.42	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1.18	0.79	2.36	3.54	1.18	0.79	1.18	0.79	1.18	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	1.78	1.02	3.30	2.29	0.25	0.51	1.02	0.76	0.51	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	6.39	0.40	0.80	3.59	2.00	0.40	0.00	1.20	0.00	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	3.34	0.84	1.25	1.67	1.67	0.00	0.42	0.00	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	3.67	1.38	3.21	1.83	0.92	0.46	0.92	2.75	0.00	0.92
Synoviocyte, donor1	11291-117A4	1.68	4.38	0.17	1.35	1.35	0.00	0.50	0.34	1.68	1.51
Synoviocyte, donor2	11368-117I9	2.01	0.50	2.01	3.18	1.01	0.00	1.51	0.50	0.50	1.51
Synoviocyte, donor3	11440-118H9	1.56	1.34	1.56	4.47	1.79	0.22	0.00	0.22	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	8.93	14.29	1.07	16.79	5.36	4.65	4.29	2.86	3.57	4.29
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	0.00	11.89	1.98	3.96	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	5.79	13.66	0.93	14.12	6.02	6.71	2.32	1.85	5.79	4.63
Tracheal Epithelial Cells, donor1	11292-117A5	1.72	2.58	3.01	0.79	0.07	1.86	0.93	1.00	1.08	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	2.32	1.16	1.55	0.00	0.39	0.39	1.93	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.86	1.15	1.72	1.15	0.00	1.72	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	13.29	8.86	6.40	9.47	4.06	1.72	3.08	1.48	8.00	2.71
Urethra, donor2	10319-105A4	46.76	21.58	10.79	8.99	21.58	16.19	3.60	1.80	10.79	8.99
Urothelial Cells, donor1	11520-119H8	1.86	2.13	1.06	1.59	0.53	1.06	3.72	1.33	1.86	0.53
Urothelial Cells, donor2	11600-120H7	2.40	2.80	2.80	0.00	0.40	0.40	0.80	0.80	1.60	0.40
Urothelial Cells, donor3	11681-122H7	4.35	1.83	1.15	0.23	0.69	0.46	2.52	0.46	1.83	1.60
Urothelial cells, donor0	11216-116B1	2.01	1.56	2.01	0.67	1.78	0.67	3.34	0.22	0.67	2.01
Whole blood (ribopure), donor090309, donation1	12179-129A1	9.79	2.67	13.35	12.46	3.56	0.89	4.45	0.00	0.00	11.57
Whole blood (ribopure), donor090309, donation2	12180-129A2	11.44	5.72	12.87	11.44	2.86	5.72	4.29	0.00	0.00	21.44
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.16	0.68	13.01	10.95	2.74	1.37	4.79	2.05	2.05	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	10.67	3.79	14.46	11.36	0.69	3.79	4.48	0.34	1.72	7.58
Whole blood (ribopure), donor090325, donation2	12177-128I8	9.88	4.65	13.36	6.97	2.91	1.74	3.49	1.16	1.74	6.97
Whole blood (ribopure), donor090612, donation1	12182-129A4	10.41	1.04	5.21	16.66	0.00	1.04	1.04	0.00	1.04	12.49
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	2.75	12.85	7.34	1.84	2.75	1.84	0.00	3.67	10.10
Whole blood (ribopure), donor090612, donation3	12184-129A6	6.39	0.91	10.95	17.35	1.83	0.00	0.91	1.83	0.00	6.39
Wilms' tumor cell line:G-401	10809-111A8	27.14	4.32	0.37	1.36	0.99	2.59	1.60	5.80	1.11	0.62
Wilms' tumor cell line:HFWT	10597-108E3	6.16	2.64	0.88	0.88	0.00	2.64	0.00	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.33	2.23	1.96	4.19	1.40	1.68	3.35	1.12	5.03	0.84
achilles tendon, donor2	10292-104G4	24.80	4.13	6.20	14.47	6.20	0.00	4.13	2.07	0.00	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	17.34	11.47	2.29	2.80	1.53	8.67	3.31	2.80	1.02	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	16.02	20.90	0.23	4.88	3.25	10.68	8.59	1.63	1.39	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	27.90	0.00	0.12	0.47	0.24	0.00	0.24	4.04	0.00	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	16.05	0.00	0.82	0.27	0.00	0.00	1.63	2.99	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	9.28	0.84	2.25	2.25	1.97	2.53	1.41	1.69	0.00	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	2.75	5.71	4.23	3.38	0.85	5.71	3.60	0.63	0.00	2.75
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	55.26	0.54	6.53	1.09	0.27	0.27	0.54	4.90	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	10.13	3.08	2.64	0.00	0.44	1.76	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.42	0.00	1.63	0.41	0.00	0.82	0.00	2.45	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	10.10	1.94	5.44	7.77	4.27	1.94	6.60	1.16	0.00	8.93
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.81	0.55	1.10	0.00	0.37	1.29	0.18	1.66	0.18	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	152.12	0.00	7.80	0.00	3.90	0.00	0.00	19.50	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	35.32	2.32	1.16	0.23	0.70	2.79	0.23	3.02	0.23	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	7.77	4.40	2.85	0.26	0.78	10.87	0.78	2.07	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	7.89	2.34	2.63	0.58	0.29	3.51	0.00	2.05	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.52	0.00	2.79	0.00	0.00	0.93	0.00	2.32	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.52	5.76	1.65	3.70	0.82	1.23	1.23	2.06	0.00	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.84	0.00	0.31	0.31	0.00	0.61	0.92	0.92	0.00	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1.28	0.43	3.41	0.43	0.00	0.85	1.71	0.43	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2.12	0.30	3.64	0.00	0.00	0.91	0.91	0.30	0.00	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1.68	0.72	2.65	0.00	0.00	0.48	0.96	0.48	0.00	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	6.90	0.00	1.11	5.79	2.67	0.89	2.23	1.56	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	13.01	2.33	2.67	1.33	1.00	4.34	0.67	1.67	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	39.02	11.15	1.86	5.57	3.72	11.15	1.86	13.01	11.15	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	17.70	2.64	13.18	0.00	0.75	3.77	0.00	3.77	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	40.12	3.93	3.49	0.44	0.44	5.67	0.00	5.67	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	22.49	22.49	0.00	0.00	1.87	15.00	1.87	11.25	7.50	0.00
adenocarcinoma cell line:IM95m	10796-110I4	7.30	4.24	0.71	2.12	0.71	1.18	4.00	3.77	2.59	1.18
adipose tissue, adult, pool1	10010-101C1	10.86	2.02	9.46	18.15	15.20	0.93	5.12	1.40	4.81	11.32
adipose, donor1	10184-103D4	13.49	21.11	0.59	4.10	2.35	1.76	10.56	9.38	5.86	2.35
adipose, donor2	10185-103D5	28.79	21.09	1.22	5.27	6.08	4.87	1.62	12.57	2.84	2.43
adipose, donor3	10186-103D6	29.95	25.05	1.09	4.36	5.72	4.08	4.90	12.80	4.08	0.82
adipose, donor4	10187-103D7	36.40	17.34	0.87	1.73	13.00	4.33	1.73	13.87	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.68	24.30	0.16	0.63	0.16	11.52	1.10	7.26	6.47	1.58
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	0.00	0.00	14.55	0.00	3.64	3.64	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.07	2.80	0.00	0.53	0.40	2.80	0.53	3.20	0.93	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	2.86	0.36	0.71	2.14	0.36	0.36	2.14	1.07	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	4.64	1.39	1.16	1.16	1.16	0.70	2.09	0.00	0.93	0.93
amniotic membrane cells, donor2	12236-129G4	7.44	6.42	2.37	4.73	4.73	1.01	2.03	1.35	2.37	1.01
amniotic membrane cells, donor3	12237-129G5	9.13	1.47	5.30	3.54	2.95	0.00	0.88	1.77	2.36	0.29
amygdala - adult, donor10196	10167-103B5	36.76	2.37	24.90	2.37	3.56	2.37	11.86	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	70.56	10.95	40.55	5.88	11.56	6.49	14.40	8.52	2.43	4.87
amygdala, newborn, donor10223	10360-105E9	40.67	3.55	14.52	3.55	3.55	4.20	4.84	4.84	1.29	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	14.01	10.95	1.15	3.31	2.04	1.91	2.55	2.80	0.76	2.42
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	4.85	1.76	0.00	0.00	0.00	1.76	0.00	1.99	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	52.78	3.67	5.01	2.67	0.33	6.68	3.67	10.69	0.33	2.00
aorta, adult, pool1	10052-101G7	19.61	6.67	8.83	8.24	18.04	1.77	4.51	5.10	3.33	7.06
appendix, adult	10189-103D9	46.19	10.48	10.87	6.21	10.48	6.21	7.76	6.99	6.99	7.76
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	31.99	13.07	1.38	0.69	1.38	7.22	2.41	4.13	4.13	0.69
artery, adult	10190-103E1	13.59	2.72	4.08	17.66	10.87	4.08	10.87	1.36	1.36	4.08
astrocytoma cell line:TM-31	10425-106D2	10.72	17.53	1.16	2.17	3.19	4.06	3.19	2.90	2.17	2.90
b cell line:RPMI1788	10427-106D4	7.73	0.15	2.23	2.68	2.97	0.45	4.61	2.53	0.30	4.61
basal cell carcinoma cell line:TE 354.T	10702-109G9	2.77	1.94	1.66	3.33	0.83	0.00	2.22	0.28	1.11	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	2.08	3.47	1.19	1.69	0.50	2.18	1.19	0.79	1.89	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	1.00	4.69	0.17	0.17	0.17	0.67	0.33	1.34	1.34	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.83	3.91	7.27	0.00	0.00	1.12	0.56	0.56	1.68	0.00
bladder, adult, pool1	10011-101C2	21.51	8.26	5.54	11.95	15.86	2.61	4.78	2.82	5.65	6.19
blood, adult, pool1	10053-101G8	2.21	0.00	6.64	0.00	0.00	0.00	4.43	0.00	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	1.71	3.43	0.00	0.86	0.86	1.71	3.43	0.00	4.28	5.14
bone marrow, adult	10192-103E3	17.55	4.05	6.07	9.45	8.10	0.67	1.35	1.35	3.37	10.80
brain, adult, donor1	10084-102B3	39.98	5.13	13.33	6.15	12.30	3.08	2.05	0.00	1.03	2.05
brain, adult, pool1	10012-101C3	31.07	4.01	29.62	4.23	8.69	2.34	7.02	2.78	1.67	2.00
brain, fetal, pool1	10085-102B4	88.16	5.34	13.36	2.67	16.03	24.04	8.01	10.69	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	11.89	21.47	0.66	0.00	0.33	5.62	0.00	1.98	7.60	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	21.10	50.05	0.37	4.87	3.74	11.48	4.12	3.12	14.10	0.12
breast, adult, donor1	10080-102A8	18.31	6.31	1.89	13.89	8.21	0.00	5.68	1.89	2.53	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	4.70	3.18	1.40	0.89	1.27	2.92	0.25	2.03	2.29	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	14.84	12.37	0.62	2.47	0.93	4.64	0.93	2.47	12.37	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.91	0.92	0.23	0.00	0.23	0.92	0.23	0.92	1.61	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	6.78	8.23	1.69	1.45	0.73	2.91	0.24	1.45	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	20.69	26.33	1.41	0.00	0.00	7.05	0.47	2.35	2.35	0.00
carcinoid cell line:NCI-H727	10735-110B6	16.74	38.17	0.00	0.66	0.22	5.80	1.53	2.84	6.89	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	32.32	12.36	3.17	0.00	0.32	12.68	0.32	0.00	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	34.34	11.98	5.32	4.26	6.12	8.52	3.73	8.52	2.40	2.40
caudate nucleus - adult, donor10196	10177-103C6	46.05	1.15	26.48	2.30	8.06	2.30	10.36	3.45	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	49.19	5.69	45.18	8.03	9.87	5.02	11.04	6.02	1.00	3.18
caudate nucleus, adult, donor10258	10379-105H1	15.28	2.29	18.34	0.76	6.11	5.35	1.53	2.29	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	50.91	2.20	16.85	2.56	4.03	2.20	1.46	6.23	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	151.49	0.00	58.27	2.91	14.57	0.00	0.00	14.57	2.91	5.83
cerebellum, adult, donor10252	10166-103B4	205.40	4.06	108.46	15.80	23.27	1.07	12.38	23.27	1.07	4.06
cerebellum, adult, pool1	10083-102B2	56.57	1.38	20.01	3.45	9.66	0.00	3.45	8.28	0.69	2.41
cerebellum, newborn, donor10223	10357-105E6	173.53	3.32	56.46	0.00	7.47	0.00	0.83	10.79	0.83	1.66
cerebral meninges, adult	10188-103D8	5.55	2.02	13.11	1.26	4.54	1.51	4.29	1.51	0.76	1.26
cerebrospinal fluid, donor2	10294-104G6	32.16	2.19	2.19	6.58	10.23	0.73	2.19	2.92	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	5.75	1.01	5.18	0.00	0.00	1.44	0.00	1.01	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	9.94	1.66	2.82	0.83	0.00	1.16	0.99	0.83	1.16	0.17
cervix, adult, pool1	10013-101C4	27.19	12.18	22.99	19.00	15.01	4.41	10.92	4.93	7.24	12.28
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	6.69	19.65	0.28	3.20	1.81	3.07	2.51	2.23	7.38	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	0.00	0.00	0.00	0.00	1.31	0.00	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	9.94	12.05	2.61	1.49	0.50	2.86	0.50	1.86	2.61	0.25
choriocarcinoma cell line:SCH	10785-110H2	13.18	12.57	1.23	1.72	0.49	2.96	0.37	4.31	2.34	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	6.40	6.40	3.32	0.47	0.47	1.66	1.19	4.27	1.90	0.00
chorionic membrane cells, donor1	12238-129G6	1.99	2.56	1.99	4.27	0.85	0.28	2.56	0.57	4.27	0.57
chorionic membrane cells, donor2	12239-129G7	3.48	6.16	0.80	3.48	1.49	0.99	3.18	0.99	2.59	1.39
chorionic membrane cells, donor3	12240-129G8	6.59	4.40	3.30	3.85	0.55	0.55	2.75	0.00	6.59	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	0.00	0.00	0.00	1.01	0.00	1.01	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	4.61	12.10	2.50	0.58	1.73	4.23	0.58	0.96	0.58	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.08	7.18	6.12	2.53	3.59	4.43	0.84	3.38	5.70	3.17
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	31.59	2.31	0.26	1.03	0.26	2.82	0.77	4.88	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	29.51	0.97	0.24	1.45	0.24	3.87	0.48	6.05	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	39.50	1.43	0.61	0.41	0.20	3.05	0.61	6.52	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	25.32	2.36	0.29	0.29	0.88	6.18	0.88	3.83	1.47	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.29	22.15	5.47	3.39	2.61	13.81	3.65	2.61	4.95	3.13
clear cell carcinoma cell line:JHOC-5	10638-108I8	2.97	1.37	0.23	0.23	0.00	2.51	0.46	1.14	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	11.45	4.68	0.17	4.16	0.69	1.39	1.56	2.43	1.91	1.04
colon carcinoma cell line:CACO-2	10513-107D9	13.36	8.42	0.55	2.75	0.92	2.38	3.48	1.46	2.75	0.73
colon carcinoma cell line:COLO-320	10420-106C6	24.71	24.33	1.52	6.46	3.42	12.54	6.08	3.42	5.70	0.38
colon, adult, donor1	10082-102B1	28.56	11.90	2.38	5.95	15.47	7.14	4.76	9.52	20.23	4.76
colon, adult, pool1	10014-101C5	21.50	7.76	5.05	17.63	13.75	2.82	8.34	2.47	6.11	3.64
colon, fetal, donor1	10070-101I7	28.43	4.94	1.85	12.36	11.12	1.85	4.33	6.18	5.56	4.33
common myeloid progenitor CMP, donor1	12130-128D6	41.25	128.34	9.17	4.58	13.75	73.34	4.58	0.00	9.17	9.17
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	50.07	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.97	6.37	0.00	0.42	0.00	1.70	0.85	1.70	1.70	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	8.45	2.41	0.00	1.06	0.30	2.87	1.51	1.96	1.51	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	9.31	2.26	0.42	1.13	0.00	2.26	1.27	2.54	1.41	0.71
corpus callosum, adult, pool1	10042-101F6	90.88	16.36	25.65	3.76	7.63	4.42	1.77	8.51	10.17	1.66
cruciate ligament, donor2	10295-104G7	28.37	4.05	11.35	6.48	10.54	4.05	4.05	2.43	3.24	6.48
diaphragm, fetal, donor1	10069-101I6	20.06	5.62	4.82	1.61	3.21	4.82	1.61	3.21	4.82	1.61
diencephalon, adult	10193-103E4	19.44	1.92	8.40	1.44	3.36	0.24	1.20	1.20	0.72	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.35	5.05	0.23	0.92	0.92	5.74	0.46	1.84	0.69	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	10.26	2.82	4.10	0.77	0.00	4.87	0.00	3.85	5.90	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.39	2.89	1.69	0.48	0.24	1.69	0.24	1.93	1.20	0.24
ductus deferens, adult	10196-103E7	43.36	20.93	7.48	13.95	7.97	1.50	9.47	5.48	11.46	5.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	20.16	2.88	2.88	5.76	2.88	2.88	8.64	4.32	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	57.38	14.71	10.30	8.09	11.77	4.41	2.94	3.68	10.30	2.94
dura mater, adult, donor1	10041-101F5	7.52	6.11	5.20	12.47	8.84	3.30	3.63	1.90	0.91	10.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.10	6.66	4.44	1.11	1.11	1.78	2.22	3.55	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.04	7.59	2.29	1.72	0.72	2.87	3.87	1.72	0.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	5.55	3.08	0.62	0.62	0.00	2.47	0.62	1.23	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	2.12	2.72	0.30	0.30	0.30	1.21	0.91	3.33	0.91	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.56	3.09	1.23	0.00	0.62	2.16	0.93	4.01	1.85	0.00
embryonic pancreas cell line:2C6	10603-108E9	7.88	2.63	0.00	3.94	0.00	0.00	1.31	2.63	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	17.09	21.12	1.68	4.02	2.35	5.03	2.68	4.02	2.35	3.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	10.51	9.06	1.45	1.45	0.36	5.26	0.18	3.44	2.90	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.01	2.73	0.32	1.45	0.80	3.06	1.77	2.09	0.80	0.32
epidermoid carcinoma cell line:A431	10426-106D3	9.12	5.00	2.00	2.22	1.45	2.33	1.00	2.67	3.11	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	8.25	3.08	1.43	1.10	0.44	1.54	2.09	0.99	0.77	1.32
epididymis, adult	10197-103E8	22.61	5.65	11.93	13.19	11.09	2.09	3.14	4.40	5.44	8.79
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3.02	6.56	1.24	16.32	5.50	3.73	6.39	1.95	2.31	11.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	6.69	3.93	1.18	0.39	0.00	3.15	0.39	1.57	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	7.86	2.88	0.13	0.00	0.00	2.36	0.00	1.31	1.31	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	7.48	5.12	0.59	0.00	0.00	4.43	0.00	2.36	3.15	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	8.29	3.36	0.67	0.00	0.00	2.58	0.00	1.34	1.68	0.00
esophagus, adult, pool1	10015-101C6	13.91	2.76	5.42	9.13	6.90	2.02	4.99	1.27	3.29	3.29
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	4.38	2.25	17.16	4.26	2.25	2.50	4.76	2.38	2.00	2.63
eye - muscle inferior rectus, donor1	10272-104E2	74.85	7.24	24.15	12.07	16.90	0.00	4.83	12.07	4.83	4.83
eye - muscle lateral, donor2	10298-104H1	27.35	6.31	8.42	8.42	10.52	0.00	2.10	2.10	2.10	2.10
eye - muscle medial, donor2	10299-104H2	41.67	1.49	4.46	5.95	7.44	0.00	4.46	10.42	4.46	7.44
eye - muscle superior, donor2	10297-104G9	32.10	0.00	10.32	8.03	8.03	5.73	5.73	4.59	2.29	2.29
eye - vitreous humor, donor1	10268-104D7	90.36	4.37	4.37	4.37	7.29	8.74	0.00	10.20	2.91	0.00
eye, fetal, donor1	10054-101G9	23.14	5.34	9.41	6.61	10.68	1.02	3.31	3.81	1.27	2.54
fibrosarcoma cell line:HT-1080	10758-110E2	3.85	6.28	1.03	2.44	1.41	2.82	1.28	0.77	1.80	2.95
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	6.65	4.99	0.71	2.14	0.95	2.61	0.95	1.90	1.66	2.85
frontal lobe, adult, pool1	10040-101F4	38.19	6.76	41.75	5.91	8.44	3.10	9.19	4.60	1.50	1.97
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.32	28.82	2.70	3.30	1.80	7.51	2.70	3.90	5.10	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1.55	2.29	0.91	0.64	0.27	1.74	0.73	0.91	1.65	1.01
gall bladder, adult	10198-103E9	12.80	12.07	5.07	14.00	14.24	2.90	4.10	1.93	8.69	5.79
gamma delta positive T cells, donor1	11937-126A2	9.66	0.54	4.29	1.61	1.61	0.00	2.15	0.54	0.00	2.15
gamma delta positive T cells, donor2	11938-126A3	12.70	1.12	2.24	0.37	1.12	1.87	1.87	0.37	0.75	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.87	2.96	5.07	1.69	3.17	0.84	0.84	0.84	0.21	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	9.09	15.67	2.51	0.58	0.39	7.74	2.71	2.32	6.77	0.19
gastric cancer cell line:AZ521	10549-107H9	20.49	62.63	3.77	3.44	1.15	28.36	3.12	4.10	12.13	0.82
gastric cancer cell line:GSS	10560-108A2	8.24	10.07	0.00	1.83	0.00	8.24	3.66	4.58	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.03	82.02	4.34	4.57	1.83	5.25	1.37	5.25	8.22	1.14
giant cell carcinoma cell line:LU65	10487-107B1	2.52	3.33	1.03	0.00	0.00	2.52	0.11	0.69	1.61	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	7.14	6.16	2.52	2.38	0.42	1.12	1.68	2.38	1.82	1.54
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.99	3.99	1.25	2.00	0.50	1.00	0.25	0.50	1.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	1.79	1.48	0.84	1.16	0.32	0.53	0.95	0.53	1.16	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	1.40	1.83	0.70	1.26	1.54	1.26	1.54	1.40	0.84	1.83
glioblastoma cell line:T98G	10485-107A8	4.86	1.55	1.77	1.43	0.99	0.77	0.77	0.99	1.32	0.66
glioma cell line:GI-1	10413-106B8	3.51	5.27	3.81	4.69	4.39	2.05	0.88	0.29	1.17	1.76
globus pallidus - adult, donor10196	10175-103C4	48.84	2.19	13.85	2.92	2.92	0.73	0.73	8.02	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	100.08	6.10	26.85	7.57	6.35	1.95	2.69	7.32	1.46	2.20
globus pallidus, adult, donor10258	10367-105F7	49.29	1.37	26.01	0.00	2.74	1.37	1.37	4.11	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	42.10	2.13	6.40	2.66	4.80	2.13	0.53	4.26	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	78.31	9.79	22.02	0.00	75.86	7.34	7.34	12.24	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	21.86	10.93	0.00	0.00	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	2.88	4.80	0.32	1.28	0.96	1.92	0.96	1.28	1.92	2.88
hIPS +CCl2, biol_rep1	14383-156B9	14.23	9.18	1.38	3.67	0.46	4.59	2.75	0.92	1.38	2.30
hIPS +CCl2, biol_rep2	14384-156C1	16.46	2.29	1.83	1.37	2.29	3.66	1.83	0.00	2.74	0.91
hIPS +CCl2, biol_rep3	14385-156C2	16.10	0.64	0.64	0.64	0.00	1.29	1.29	2.58	1.93	0.64
hIPS, biol_rep1	14380-156B6	23.00	4.31	0.00	2.87	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	25.38	5.49	0.00	2.74	0.00	2.74	1.37	3.43	1.37	0.69
hIPS, biol_rep3	14382-156B8	36.41	1.10	24.28	2.21	2.21	1.10	7.72	1.10	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	7.47	10.92	0.57	0.00	0.00	10.34	0.00	0.86	2.01	0.00
heart - mitral valve, adult	10205-103F7	33.78	5.08	13.45	17.64	19.43	1.79	4.48	4.19	8.37	8.37
heart - pulmonic valve, adult	10206-103F8	23.27	6.54	13.34	14.12	28.50	2.88	3.14	1.83	6.54	6.01
heart - tricuspid valve, adult	10207-103F9	49.96	4.16	5.83	9.16	9.16	3.33	0.83	7.49	5.00	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	14.69	7.35	6.94	14.69	17.34	2.24	6.94	3.06	2.45	2.86
heart, adult, diseased, donor1	10051-101G6	11.92	6.39	14.90	18.31	31.94	1.28	12.35	0.00	6.39	5.96
heart, adult, pool1	10016-101C7	7.82	5.06	5.98	29.21	26.91	1.15	14.26	0.23	3.45	6.21
heart, fetal, pool1	10046-101G1	34.81	24.44	15.92	18.69	23.00	3.80	10.17	5.13	11.81	4.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	4.01	3.09	0.31	3.09	1.85	0.31	3.39	1.85	3.39	3.09
hepatoblastoma cell line:HuH-6	10633-108I3	86.81	46.38	0.00	0.00	1.19	11.89	1.19	13.08	10.70	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	28.62	10.17	0.00	2.32	2.32	3.65	2.76	3.43	2.43	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	20.75	9.59	0.12	3.28	2.31	4.13	3.03	3.16	1.70	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	31.43	11.92	0.00	4.35	2.53	6.47	2.93	4.55	2.32	1.21
hepatoma cell line:Li-7	10484-107A7	5.00	15.57	0.33	7.67	2.78	1.89	2.22	0.44	1.56	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.74	27.84	0.00	1.71	0.60	10.35	2.61	2.71	3.32	1.21
hippocampus - adult, donor10196	10169-103B7	41.64	2.84	27.44	0.00	4.73	2.84	9.46	5.68	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	81.03	8.57	38.98	8.78	11.23	3.27	10.20	8.98	2.25	3.47
hippocampus, adult, donor10258	10374-105G5	41.33	1.00	23.90	1.99	4.98	1.49	5.48	3.98	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	42.65	1.41	14.45	2.47	4.23	1.41	3.17	4.23	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	15.26	15.87	0.00	1.83	0.00	6.71	3.05	4.88	2.44	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.21	21.21	0.00	0.98	0.00	6.68	2.95	4.52	1.57	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	15.49	16.25	0.00	0.51	0.51	6.60	2.29	3.81	1.27	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.70	9.02	0.00	5.64	2.26	4.51	9.02	7.33	3.95	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	42.60	12.14	0.26	12.14	3.87	4.39	6.97	5.68	2.07	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	26.19	6.07	0.00	5.69	3.04	3.42	7.21	5.69	2.66	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	42.92	26.28	0.58	5.26	6.42	7.59	7.30	11.97	2.63	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	52.56	29.30	0.86	7.32	7.32	7.11	6.46	15.73	3.23	4.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	51.72	20.85	1.67	5.84	6.67	8.34	2.09	11.26	1.25	3.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	14.68	19.89	0.71	2.13	2.37	2.84	4.97	2.37	1.66	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.34	21.54	0.80	3.70	5.14	3.38	3.86	6.75	1.77	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	28.95	0.67	4.04	3.37	4.71	1.35	2.69	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	17.68	17.53	0.00	1.88	0.31	8.14	1.41	4.23	1.56	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	23.58	17.69	0.00	2.46	0.00	7.86	0.98	2.95	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	11.35	0.00	1.75	0.00	6.98	1.75	2.62	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	52.50	15.46	0.57	9.93	6.87	3.63	4.77	12.03	3.05	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.66	14.39	1.31	4.80	6.11	4.36	5.67	10.90	2.18	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.49	11.99	1.50	4.00	5.50	2.00	5.50	7.50	4.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.95	19.97	2.07	10.36	12.62	6.03	3.20	8.29	2.07	3.01
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	29.56	18.64	1.36	8.64	7.73	4.55	3.18	13.19	2.73	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	30.07	21.30	1.88	1.88	9.40	4.39	4.70	8.46	1.57	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	33.15	18.45	1.47	3.43	3.59	3.43	2.29	7.02	2.45	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	27.00	12.48	1.16	5.23	3.48	4.64	2.03	6.39	1.16	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	32.28	17.64	1.79	2.09	5.38	2.39	1.79	6.58	1.20	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.46	17.37	0.00	1.48	0.74	7.94	1.11	5.17	1.85	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	21.68	18.83	0.00	1.14	0.86	9.98	1.14	4.56	2.28	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	7.35	18.78	0.00	1.22	0.82	9.80	1.22	4.08	2.45	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	28.87	11.97	1.41	3.52	3.17	2.46	3.17	6.34	2.46	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.81	10.14	0.95	5.07	4.12	1.90	1.90	3.80	1.90	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	25.42	10.29	0.91	5.45	5.75	2.12	3.63	5.14	2.12	2.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	35.16	16.55	1.03	2.07	6.72	5.17	2.59	9.83	1.55	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	39.85	15.94	1.33	2.66	3.32	4.65	3.98	10.63	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.81	15.65	1.54	1.80	2.57	3.08	1.80	4.36	2.31	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.80	14.06	1.28	3.32	3.83	1.02	2.56	3.32	0.51	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	23.47	2.27	1.51	1.51	0.76	2.27	4.54	3.03	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	19.49	12.77	1.68	1.34	3.70	2.35	5.04	3.02	1.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.43	20.53	0.00	1.69	0.97	5.55	1.69	4.11	3.38	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	14.26	18.27	0.00	0.00	0.45	4.90	0.45	5.35	0.89	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	19.51	18.54	0.00	0.98	0.00	12.20	1.46	3.90	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.84	10.09	0.61	10.09	7.95	2.75	7.33	6.42	3.36	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	45.55	3.25	6.51	13.01	9.76	13.01	3.25	13.01	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	28.79	10.26	0.99	7.61	8.60	1.65	10.59	3.97	1.65	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.97	19.16	1.09	9.30	12.59	2.19	3.83	8.21	1.64	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	28.23	13.03	0.36	4.34	8.69	3.26	4.34	9.77	1.45	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	35.23	8.90	1.42	4.27	9.25	2.14	6.05	6.76	1.07	4.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	26.25	13.13	0.00	4.77	3.58	2.39	1.19	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	21.26	19.91	2.30	2.98	3.93	2.03	4.47	4.33	0.81	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.82	12.12	0.54	1.89	4.31	2.69	2.16	5.39	1.89	1.08
immature langerhans cells, donor1	11904-125F5	1.45	0.97	3.87	0.73	0.00	1.45	0.48	0.24	1.21	0.00
immature langerhans cells, donor2	11905-125F6	22.18	3.96	7.92	3.96	0.79	2.38	1.58	3.17	0.79	0.79
insula, adult, pool1	10039-101F3	43.72	9.56	60.75	5.39	12.59	5.30	9.94	5.77	2.84	3.22
keratoacanthoma cell line:HKA-1	10791-110H8	8.13	2.93	1.63	0.00	0.33	0.33	0.00	2.93	0.33	0.00
kidney, adult, pool1	10017-101C8	16.52	5.91	5.21	24.73	12.32	0.90	12.72	1.30	1.10	4.41
kidney, fetal, pool1	10045-101F9	49.52	24.76	10.26	22.64	18.25	5.38	12.66	7.92	6.01	6.22
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.95	7.24	0.28	3.41	2.27	3.12	2.41	2.56	1.85	1.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.94	0.97	0.14	0.00	0.00	0.41	0.00	0.41	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	3.85	2.02	1.28	0.92	0.18	1.10	0.73	1.10	2.75	0.37
left atrium, adult, donor1	10079-102A7	9.26	3.27	6.54	4.36	5.45	0.00	2.72	4.90	1.63	1.63
left ventricle, adult, donor1	10078-102A6	7.08	1.01	4.05	13.15	15.17	1.01	7.58	2.53	1.52	3.54
leiomyoblastoma cell line:G-402	10721-110A1	8.76	12.31	0.00	1.37	0.55	6.57	0.00	3.56	9.30	0.55
leiomyoma cell line:10964C	10569-108B2	1.44	0.00	4.31	5.03	1.44	0.00	2.51	0.00	0.00	1.80
leiomyoma cell line:15242A	10570-108B3	1.63	0.54	1.09	2.17	0.54	0.00	1.63	1.63	1.09	0.54
leiomyoma cell line:15425	10571-108B4	1.21	0.97	3.16	3.89	0.73	0.49	0.73	0.73	0.73	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	6.35	0.00	0.00	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	2.09	3.14	1.05	0.00	2.09	1.05	2.09	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	8.74	6.02	1.42	0.35	0.35	5.19	0.12	2.13	0.35	0.47
liposarcoma cell line:KMLS-1	10782-110G8	5.15	0.94	3.91	1.41	0.78	0.62	0.47	1.09	0.47	1.56
liposarcoma cell line:SW 872	10726-110A6	12.31	0.97	1.83	3.29	2.44	1.10	2.19	2.44	1.22	3.05
liver, adult, pool1	10018-101C9	6.16	2.27	1.94	4.54	2.43	0.49	2.59	0.32	0.49	0.81
liver, fetal, pool1	10086-102B5	11.29	1.88	0.94	0.00	1.88	1.88	2.82	1.88	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	50.60	4.67	11.52	4.37	7.15	1.60	2.48	5.40	0.58	1.60
locus coeruleus, adult, donor10252	10165-103B3	63.49	4.06	16.24	4.06	5.17	1.85	6.09	7.57	0.92	1.85
locus coeruleus, adult, donor10258	10375-105G6	24.83	4.51	12.41	2.82	3.95	1.41	3.10	3.39	1.13	1.69
locus coeruleus, newborn, donor10223	10362-105F2	37.44	4.21	19.77	2.10	2.10	2.10	1.26	2.10	0.84	1.68
lung adenocarcinoma cell line:A549	10499-107C4	2.35	8.30	0.00	0.14	0.14	1.66	0.28	1.11	2.49	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	8.27	0.00	2.76	0.69	4.14	1.38	0.69	11.72	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	5.27	8.04	0.66	1.05	0.13	5.80	1.45	2.11	8.83	0.66
lung, adult, pool1	10019-101D1	17.48	6.62	3.78	5.43	4.37	2.48	3.07	2.24	6.26	2.36
lung, fetal, donor1	10068-101I5	64.50	14.56	21.41	10.56	12.27	7.71	1.71	9.70	17.98	7.42
lung, right lower lobe, adult, donor1	10075-102A3	22.91	6.42	5.04	5.96	6.87	2.29	3.21	10.08	8.71	5.04
lymph node, adult, donor1	10077-102A5	9.47	1.89	3.79	4.26	3.79	4.26	3.31	2.37	1.89	5.68
lymphangiectasia cell line:DS-1	10727-110A7	5.26	2.85	1.97	1.75	0.88	1.10	0.66	0.66	0.66	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	19.32	3.17	9.21	6.34	4.08	1.81	8.15	2.26	0.30	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.04	11.89	22.94	0.00	2.55	5.10	1.70	4.25	0.85	0.00
mature adipocyte, donor1	12231-129F8	3.11	4.00	3.55	12.88	14.65	1.33	6.66	0.00	5.33	3.11
mature adipocyte, donor2	12232-129F9	3.32	4.15	4.77	6.02	8.72	1.04	3.74	0.62	6.64	3.32
mature adipocyte, donor3	12233-129G1	4.27	3.32	4.27	13.04	7.11	0.71	3.56	0.71	5.93	2.37
mature adipocyte, donor4	12234-129G2	4.21	4.47	3.95	14.48	16.32	0.79	4.47	0.53	5.26	3.16
maxillary sinus tumor cell line:HSQ-89	10414-106B9	35.50	112.93	7.39	108.41	21.44	37.41	21.21	14.06	30.74	8.34
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	1.13	30.46	4.51	13.54	1.13	3.38	1.13	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	76.87	6.07	45.42	14.53	14.53	3.68	18.94	10.11	2.02	2.39
medial frontal gyrus, adult, donor10258	10368-105F8	22.24	2.22	26.69	1.91	4.13	2.22	4.13	2.54	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	29.85	5.12	37.96	1.28	5.12	5.97	2.99	5.12	1.71	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	40.50	3.21	41.68	3.54	6.92	2.53	8.27	6.58	0.34	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	95.29	9.76	47.11	12.52	13.79	4.46	14.64	12.10	1.91	1.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	0.00	40.45	0.00	0.00	1.93	5.78	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	588.50	0.00	287.07	0.00	14.35	14.35	0.00	28.71	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	41.28	3.59	19.38	2.51	2.51	5.03	3.95	6.46	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	35.04	2.60	9.73	2.60	3.24	0.65	5.84	5.19	1.95	3.24
medulla oblongata, adult, donor10252	10155-103A2	56.66	4.18	16.41	4.49	6.04	1.39	4.80	5.42	2.17	1.70
medulla oblongata, adult, pool1	10038-101F2	43.83	10.61	18.53	4.57	8.16	3.18	4.33	5.39	4.16	2.45
medulla oblongata, newborn, donor10223	10361-105F1	35.76	1.39	9.37	2.43	1.74	0.69	1.39	3.12	1.04	0.35
medulloblastoma cell line:D283 Med	10838-111E1	53.36	23.25	9.08	0.44	1.55	19.48	1.99	5.98	2.44	0.00
medulloblastoma cell line:ONS-76	10759-110E3	7.21	8.80	0.49	0.61	0.86	4.77	0.86	2.57	2.20	1.10
melanoma cell line:COLO 679	10514-107E1	6.04	2.87	1.87	2.87	1.87	2.30	2.01	0.86	2.01	1.01
melanoma cell line:G-361	10465-106H6	18.46	6.52	0.00	0.54	0.81	3.80	0.00	2.44	1.90	0.27
meningioma cell line:HKBMM	10691-109F7	5.43	2.71	0.72	1.63	1.09	0.36	1.99	1.27	2.35	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	41.41	37.01	0.88	0.00	0.88	18.50	1.76	6.17	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	53.66	43.29	7.26	1.30	3.37	19.70	1.81	9.59	0.78	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	2.92	0.31	1.69	1.23	0.77	0.61	1.07	0.61	1.23	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	3.64	1.64	1.27	2.73	0.73	0.73	0.55	0.55	1.64	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	2.90	0.41	2.07	2.07	0.83	0.00	0.83	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	2.11	1.55	4.07	1.97	0.70	0.14	1.69	0.56	1.83	2.11
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	2.50	1.54	2.12	4.43	1.73	0.19	0.58	0.19	1.16	2.50
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	2.78	0.69	4.86	4.16	2.08	0.00	0.69	0.00	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	1.37	0.69	0.69	2.23	0.86	0.17	0.69	0.17	0.69	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	2.88	1.15	1.61	4.49	2.07	0.12	1.50	0.92	1.27	3.57
mesenchymal precursor cell - cardiac, donor3	11754-123G8	2.65	3.18	0.80	2.79	1.59	1.06	0.93	0.93	1.19	2.25
mesenchymal precursor cell - cardiac, donor4	11755-123G9	2.16	6.21	0.41	1.49	0.81	1.22	1.22	0.27	2.70	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	4.27	5.26	0.85	2.28	0.57	1.28	2.13	1.00	2.42	1.99
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.95	3.29	1.98	1.65	0.99	0.33	0.33	0.99	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	3.74	3.46	0.55	2.21	0.14	0.97	0.14	0.55	1.38	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	3.14	1.40	1.05	3.14	1.05	0.00	2.09	0.35	0.35	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	2.25	1.43	0.82	1.84	0.61	0.20	1.63	0.20	1.02	1.22
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	3.59	3.95	0.72	3.24	1.44	0.00	1.08	1.44	0.72	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	4.34	2.90	1.24	2.48	0.72	0.41	2.17	0.93	1.66	2.59
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	2.74	0.91	1.14	5.02	1.82	0.23	3.19	0.46	0.23	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	3.36	2.10	2.10	1.68	1.26	0.84	1.68	0.42	1.26	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	2.39	4.48	0.90	1.20	0.45	1.05	1.05	0.60	1.49	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	4.29	1.93	1.49	2.63	0.35	0.61	1.66	0.26	0.79	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.52	3.68	1.84	6.63	2.21	1.10	3.68	0.74	2.95	2.95
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.58	4.58	0.86	3.15	1.14	0.29	1.43	2.00	1.72	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	1.68	3.79	1.26	1.68	0.42	0.00	1.26	1.26	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	3.20	0.00	3.20	3.20	0.00	0.46	0.46	0.46	0.00	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	2.05	1.02	2.30	1.28	1.28	0.51	0.51	0.26	0.51	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	2.88	0.26	4.71	1.31	0.52	0.00	0.26	0.52	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	4.93	1.54	1.54	4.01	0.62	0.31	0.62	0.00	0.92	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	1.88	0.00	4.24	3.06	1.18	0.24	0.71	0.47	0.24	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	2.37	0.00	2.37	2.03	1.35	0.34	1.02	0.34	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	2.75	0.79	2.36	2.36	0.39	0.00	0.00	0.00	0.00	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	3.24	0.93	0.93	4.17	1.39	0.46	0.00	0.46	0.46	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	3.75	0.29	2.88	1.73	1.15	0.00	0.87	0.29	0.29	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	2.68	0.45	3.57	2.90	2.23	0.67	0.67	0.00	0.00	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	3.36	0.24	2.64	2.16	0.72	0.24	0.96	0.48	0.00	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	5.13	0.73	0.73	3.67	0.73	0.73	2.20	0.73	2.20	4.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	4.03	0.00	3.02	4.03	1.68	0.34	1.01	0.34	0.00	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	3.68	0.00	2.46	3.68	1.23	0.00	1.23	0.82	0.00	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.15	0.43	4.30	3.01	1.29	0.43	0.00	0.43	0.00	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	0.00	5.47	2.73	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	0.00	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	2.60	0.65	1.30	3.57	1.30	0.00	0.97	0.00	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	0.00	1.45	1.45	0.00	0.00	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1.07	0.00	0.53	4.26	2.67	0.53	0.53	1.07	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	1.64	1.64	0.82	0.82	0.82	1.64	0.82	0.00	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	2.33	0.39	1.55	5.44	1.55	0.00	0.39	0.39	0.39	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	2.10	0.00	2.10	4.20	0.00	0.00	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1.99	0.00	0.99	2.98	1.99	0.99	2.98	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	1.78	0.00	2.96	3.56	0.00	0.00	1.78	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	0.00	2.44	7.31	3.66	1.22	0.00	0.00	0.00	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	2.53	0.00	1.27	6.97	3.80	0.00	0.63	0.63	0.00	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	2.76	0.34	2.07	7.24	2.76	0.34	1.38	0.00	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	2.15	2.15	4.30	4.30	0.00	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	3.99	3.99	0.00	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00	3.44	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	0.00	2.44	8.15	4.07	0.00	0.41	0.41	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	0.79	3.18	8.74	4.77	1.59	1.59	0.00	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	0.00	1.77	2.36	6.48	0.00	1.77	0.00	0.00	4.72
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.05	0.62	1.56	6.23	5.92	0.00	0.94	0.31	0.00	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	0.00	2.67	10.69	4.01	0.00	1.34	0.00	0.00	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	0.00	1.18	4.73	4.73	0.00	1.18	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	0.00	5.14	17.98	5.14	0.00	2.57	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.13	0.69	4.13	9.64	2.75	0.00	1.38	0.00	0.69	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	5.44	1.48	1.98	7.42	5.44	0.49	0.99	0.00	0.00	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	1.12	4.49	7.85	5.61	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.82	0.64	1.27	12.09	6.36	0.00	0.64	0.00	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	3.63	0.40	0.81	4.43	5.24	0.81	0.81	0.40	2.01	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	2.18	0.00	8.72	8.72	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	1.27	0.00	5.07	2.53	0.00	1.27	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	1.82	3.03	6.68	10.92	0.00	1.82	0.00	1.21	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	0.00	13.56	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	8.24	0.00	0.00	5.77	6.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1.59	0.60	2.18	4.17	2.38	0.20	0.79	0.40	0.00	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	1.95	0.65	1.62	2.27	3.24	0.32	1.30	0.00	0.65	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	2.04	0.00	5.09	4.07	0.00	1.02	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	3.09	4.64	2.32	3.87	2.32	0.77	0.00	1.55	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	3.07	3.54	0.24	2.83	0.94	1.42	4.25	1.89	3.31	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	6.72	6.02	2.09	6.72	3.71	2.55	3.24	1.62	1.62	3.24
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	0.00	0.00	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	0.72	0.21	1.13	1.44	0.41	0.21	0.72	0.31	0.10	0.51
mesothelioma cell line:Mero-25	10850-111F4	2.50	0.68	0.23	0.45	0.23	0.45	0.45	0.68	0.00	0.91
mesothelioma cell line:Mero-41	10851-111F5	1.71	0.49	1.47	0.98	0.24	0.49	0.49	1.47	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	2.21	1.11	1.33	0.44	0.00	0.89	0.22	1.55	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	3.42	1.05	1.58	0.79	0.26	0.79	0.26	1.05	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	1.02	0.51	1.36	0.34	0.51	0.17	1.36	0.51	0.17	0.68
mesothelioma cell line:Mero-84	10855-111F9	1.01	0.00	1.01	0.51	0.00	0.00	1.01	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	4.14	1.24	2.28	1.86	1.86	1.24	0.83	1.04	1.24	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	2.48	0.00	1.49	4.14	1.66	0.99	3.64	0.50	0.66	1.82
mesothelioma cell line:NCI-H226	10846-111E9	1.27	0.36	2.53	1.99	0.90	0.72	2.17	0.36	0.36	1.27
mesothelioma cell line:NCI-H2452	10848-111F2	2.05	0.85	3.07	6.15	2.39	0.68	2.39	1.37	0.34	2.05
mesothelioma cell line:NCI-H28	10845-111E8	1.27	1.27	1.27	0.25	0.25	0.25	0.51	0.00	1.27	0.00
mesothelioma cell line:No36	10857-111G2	1.63	2.61	1.63	0.65	1.63	0.00	0.33	0.33	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	2.44	0.27	1.63	2.98	0.27	0.81	2.71	0.81	0.27	1.08
migratory langerhans cells, donor1	11901-125F2	2.69	0.77	5.57	0.00	0.00	1.15	0.00	1.15	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	2.44	0.73	4.88	0.00	0.00	0.49	0.00	0.85	0.73	0.00
migratory langerhans cells, donor3	11903-125F4	3.77	0.54	6.46	0.18	0.18	0.72	0.18	0.36	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	5.22	1.96	1.31	1.31	0.33	0.00	0.98	1.63	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.09	2.12	0.64	0.21	0.21	0.64	1.06	1.27	0.00	2.12
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1.61	3.23	0.23	2.07	0.69	1.84	1.38	1.15	0.92	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	3.62	1.33	1.90	0.95	0.57	1.14	1.33	0.76	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6.84	1.85	2.40	0.00	0.00	1.29	0.18	1.66	0.37	0.00
myeloma cell line:PCM6	10474-106I6	0.99	6.72	0.00	3.16	3.36	3.16	0.59	0.59	1.78	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	4.06	1.52	1.52	2.54	0.51	1.01	1.01	0.51	2.54	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	5.69	7.06	0.78	2.75	2.16	1.77	1.18	2.75	3.14	1.77
nasal epithelial cells, donor1, tech_rep1	12226-129F3	1.45	0.33	1.45	0.45	0.00	0.45	0.00	1.00	0.22	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	0.51	0.66	1.69	0.29	0.00	0.74	0.07	0.66	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	4.42	0.55	1.66	0.55	4.42	0.00	0.55	2.76	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	25.31	10.58	2.07	0.00	1.38	7.36	0.46	3.68	1.38	0.00
neuroblastoma cell line:NB-1	10539-107G8	7.30	8.79	2.25	1.31	1.87	2.06	0.75	0.00	2.99	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	35.01	43.65	0.21	0.00	0.21	11.60	1.48	2.74	0.63	0.00
neuroblastoma cell line:NH-12	10555-107I6	24.23	15.47	1.49	0.37	1.86	3.17	0.19	2.42	2.80	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	66.90	50.29	0.95	0.24	0.24	23.96	0.24	4.98	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.64	59.39	1.43	1.74	3.64	25.18	1.74	4.91	2.69	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	24.35	22.74	1.81	2.01	2.62	9.46	2.42	4.63	1.01	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.15	6.99	0.64	1.27	1.27	10.81	1.27	7.63	0.00	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	4.26	2.93	0.27	1.86	1.86	0.53	0.80	1.60	1.33	1.06
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	14.87	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	13.28	0.00	0.00	26.56	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	0.00	18.94	0.00	0.00	9.47	9.47	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	74.75	14.54	1.35	0.51	0.00	6.60	0.17	6.76	3.38	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	5.60	1.60	0.00	0.00	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	3.85	2.24	2.89	2.89	0.64	1.92	0.64	1.28	1.28	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	5.52	1.58	1.58	0.79	1.31	1.05	2.10	1.05	0.79	0.53
nucleus accumbens, adult, pool1	10037-101F1	41.34	7.78	46.49	5.44	9.84	5.25	7.41	5.25	2.81	1.31
occipital cortex - adult, donor10196	10172-103C1	61.81	2.06	30.91	6.18	18.54	0.00	10.30	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	130.16	8.05	31.94	14.22	13.15	2.68	16.10	9.66	2.42	3.49
occipital cortex, newborn, donor10223	10355-105E4	37.49	2.18	19.29	3.28	1.46	3.28	4.37	6.19	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	30.70	5.77	20.20	2.36	10.50	3.15	5.77	5.25	1.57	2.10
occipital lobe, fetal, donor1	10073-102A1	142.46	20.17	12.87	0.43	6.87	20.60	2.15	24.46	0.00	2.15
occipital pole, adult, pool1	10036-101E9	30.43	3.86	31.46	6.23	10.72	3.07	8.36	3.78	2.37	1.81
olfactory region, adult	10195-103E6	42.22	3.82	34.58	4.78	9.74	2.87	5.73	4.20	1.53	3.44
optic nerve, donor1	10277-104E7	176.09	18.01	4.00	0.00	4.00	6.00	0.00	14.01	6.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	12.42	2.96	4.78	0.46	0.34	0.80	0.57	2.62	0.91	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	4.95	3.85	1.65	0.27	0.55	2.20	0.96	1.92	1.51	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	2.88	1.35	3.56	1.02	0.68	2.54	0.34	0.51	0.68	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.89	3.47	0.46	0.58	0.35	1.39	0.81	1.16	1.85	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	6.47	2.35	1.18	2.06	0.88	0.29	0.88	0.59	1.47	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	10.28	69.14	0.00	10.28	1.87	25.23	4.67	0.93	20.56	4.67
osteosarcoma cell line:HS-Os-1	10558-107I9	13.57	4.88	3.82	0.00	0.00	2.54	0.00	1.48	1.91	0.00
ovary, adult, pool1	10020-101D2	13.02	6.20	7.95	6.90	9.61	2.45	4.11	3.06	1.66	3.84
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	10.08	5.68	0.00	0.18	0.00	1.83	0.00	2.20	0.37	0.00
pancreas, adult, donor1	10049-101G4	16.93	19.75	2.82	1.88	4.70	1.88	1.88	4.70	15.05	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.14	6.15	3.07	2.52	1.68	0.84	0.56	5.59	2.52	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	4.77	4.94	2.38	1.02	1.02	1.36	0.51	0.85	0.85	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	5.96	6.95	1.32	1.99	0.17	3.15	1.99	1.32	3.15	2.32
paracentral gyrus, adult, pool1	10035-101E8	35.88	5.40	40.00	5.58	8.15	3.66	7.60	4.76	1.92	1.92
parietal cortex, adult, donor10258	10373-105G4	27.16	1.47	25.69	2.20	5.87	0.73	5.14	2.94	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	51.73	1.88	29.15	2.82	4.70	4.70	5.64	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	80.95	9.98	52.45	11.40	16.25	2.00	17.39	8.84	1.43	3.42
parietal lobe, adult, pool1	10034-101E7	43.18	7.05	43.80	5.46	8.81	2.91	8.90	3.26	1.76	1.76
parietal lobe, fetal, donor1	10072-101I9	229.85	29.10	24.25	3.88	7.76	16.49	0.00	18.43	3.88	0.97
parietal lobe, newborn, donor10223	10356-105E5	42.99	2.99	19.44	1.50	3.74	7.10	6.73	4.49	1.87	1.50
parotid gland, adult	10199-103F1	6.78	3.08	3.70	16.65	7.40	1.85	1.23	0.62	1.85	1.23
penis, adult	10200-103F2	20.95	5.37	15.58	14.50	16.11	1.61	4.30	3.22	6.45	4.83
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	21.57	37.19	2.60	5.39	15.62	32.54	3.53	2.97	0.37	2.60
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	10.64	13.99	1.02	1.17	2.48	1.75	0.44	1.60	4.66	0.73
pineal gland - adult, donor10196	10179-103C8	217.37	9.03	7.10	0.65	3.87	1.29	1.29	32.90	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	374.87	10.07	11.25	7.11	5.92	1.78	4.74	39.68	1.18	2.96
pineal gland, adult, donor10258	10377-105G8	166.80	4.39	1.88	1.88	3.76	1.25	0.63	23.83	2.51	0.63
pituitary gland - adult, donor10196	10180-103C9	62.73	4.05	51.60	2.02	11.13	0.00	1.01	7.08	1.01	3.04
pituitary gland, adult, donor10252	10162-103A9	99.55	11.99	91.73	9.38	8.86	3.65	11.47	11.99	3.65	2.08
pituitary gland, adult, donor10258	10378-105G9	24.69	1.70	28.09	0.85	4.26	0.00	1.70	5.11	0.85	0.00
placenta, adult, pool1	10021-101D3	7.10	13.87	2.80	5.70	3.12	2.90	1.83	1.72	9.03	1.72
plasma cell leukemia cell line:ARH-77	10840-111E3	12.98	6.22	1.19	0.00	0.26	7.15	0.13	1.46	2.12	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	15.56	4.82	0.47	2.65	1.87	2.18	1.25	1.40	3.27	2.02
pons, adult, pool1	10033-101E6	28.57	6.28	17.90	3.96	5.16	1.72	6.20	4.13	2.58	1.55
postcentral gyrus, adult, pool1	10032-101E5	36.09	4.27	40.45	5.84	9.33	2.96	9.85	4.53	1.57	1.31
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	2.09	2.09	6.27	0.00	2.09	2.09	2.09	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	11.02	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	7.72	4.37	0.00	1.02	0.15	2.18	0.58	1.31	1.31	0.44
prostate cancer cell line:PC-3	10439-106E7	9.80	9.98	0.73	5.99	2.36	5.63	4.36	1.82	1.27	1.63
prostate, adult, pool1	10022-101D4	18.50	12.15	7.07	15.96	10.52	4.63	10.25	3.90	12.52	5.35
putamen, adult, donor10196	10176-103C5	38.95	2.60	47.68	3.30	9.21	3.07	6.85	7.32	0.47	1.65
putamen, adult, donor10252	10152-102I8	29.41	0.00	17.65	5.88	5.88	1.96	19.61	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	2.19	15.30	1.09	0.00	0.00	0.00	3.28	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	20.54	2.90	21.75	3.87	5.07	1.93	4.59	1.69	0.97	0.72
putamen, newborn, donor10223	10365-105F5	41.98	0.75	23.99	5.25	1.50	0.75	3.00	4.50	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	16.00	9.60	1.16	5.53	3.49	8.15	2.33	2.91	4.65	0.58
rectum, fetal, donor1	10067-101I4	70.94	11.13	5.56	5.56	18.08	4.17	4.17	27.82	5.56	11.13
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.51	1.70	1.91	3.18	0.85	0.64	3.18	1.70	1.06	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	9.53	2.49	4.56	1.24	0.41	1.24	2.90	4.14	1.66	0.41
retina, adult, pool1	10030-101E3	44.03	8.25	19.88	11.33	14.51	2.19	4.37	7.85	2.88	4.77
retinoblastoma cell line:Y79	10475-106I7	42.61	37.41	4.42	1.82	3.90	9.87	2.34	8.05	7.53	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	31.97	10.70	0.61	1.35	0.25	2.58	2.09	7.38	2.09	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	22.21	62.43	1.97	6.19	4.78	15.75	3.09	5.62	8.44	3.66
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	16.67	0.76	10.61	8.34	7.58	1.52	3.79	6.82	1.52
salivary acinar cells, donor1	11771-123I7	10.20	1.94	4.69	0.81	1.62	0.97	0.16	2.43	1.78	0.16
salivary acinar cells, donor2	11772-123I8	8.40	0.55	6.75	1.10	1.79	0.55	0.28	1.38	0.69	0.41
salivary acinar cells, donor3	11773-123I9	21.19	3.97	3.31	5.96	4.63	1.99	0.00	7.94	1.32	1.32
salivary gland, adult, pool1	10093-102C3	27.45	17.16	4.58	6.29	1.72	3.43	0.57	1.72	14.87	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	3.71	2.61	4.47	1.85	1.18	1.60	1.77	1.77	0.93	1.77
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	3.17	3.53	3.53	1.65	1.88	1.41	2.23	2.47	0.94	1.76
seminal vesicle, adult	10201-103F3	39.68	19.58	13.23	17.46	25.40	4.76	6.35	7.94	19.58	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.89	4.86	0.73	1.94	0.73	2.43	0.73	1.21	2.67	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.04	1.76	1.01	0.50	1.26	0.75	0.75	0.50	0.50	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	7.02	0.00	2.01	0.00	0.00	2.01	1.00	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	12.76	25.12	1.34	9.67	4.16	5.64	4.57	2.55	3.76	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	7.85	5.53	1.44	4.42	1.77	1.77	2.65	1.88	0.99	1.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	2.71	3.61	2.58	0.77	0.65	2.32	1.16	0.52	2.06	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	32.63	0.71	9.93	29.79	31.21	1.42	16.31	2.84	2.13	7.80
skeletal muscle, adult, pool1	10023-101D5	12.59	2.16	9.36	34.30	22.19	1.32	18.71	1.08	1.32	6.24
skeletal muscle, fetal, donor1	10066-101I3	10.05	20.10	5.03	4.02	14.07	4.02	0.00	1.01	2.01	0.00
skin, adult, donor1	10074-102A2	27.14	6.79	6.79	13.57	6.79	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	23.36	7.57	10.73	2.52	7.57	10.10	0.63	7.57	6.94	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	37.69	10.67	0.33	0.33	0.00	12.67	0.33	8.34	2.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	74.07	16.71	5.36	4.41	5.67	3.47	6.30	6.93	1.89	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	36.04	25.83	1.54	0.96	0.00	17.73	0.39	14.46	9.06	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	18.30	44.34	0.99	14.34	10.55	5.60	3.79	3.63	6.76	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	51.15	40.21	0.64	0.32	0.48	25.41	1.61	9.49	3.70	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	49.90	43.58	7.19	1.09	1.31	7.19	0.65	4.58	4.14	0.44
small intestine, adult, pool1	10024-101D6	11.23	4.90	3.70	21.98	8.36	1.91	5.61	1.79	5.02	3.70
small intestine, fetal, donor1	10064-101I1	14.74	4.18	3.19	4.18	9.09	2.70	2.46	4.42	2.46	2.95
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.75	35.90	4.62	0.00	0.00	8.72	0.51	1.03	12.31	0.00
smooth muscle, adult, pool1	10048-101G3	37.22	10.08	6.46	14.22	17.32	1.29	5.94	4.39	7.24	4.65
somatostatinoma cell line:QGP-1	10781-110G7	10.72	46.10	0.54	0.27	0.27	5.09	0.00	4.02	10.72	0.00
spinal cord - adult, donor10196	10181-103D1	62.40	6.19	14.91	3.44	6.19	2.06	2.75	6.19	1.15	1.61
spinal cord, adult, donor10252	10159-103A6	52.44	9.86	21.68	4.34	4.34	3.55	1.18	5.52	3.94	3.15
spinal cord, adult, donor10258	10369-105F9	31.82	2.77	17.29	0.00	4.15	0.69	1.38	0.69	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	45.74	17.08	8.54	1.83	7.93	3.05	1.83	7.32	7.93	2.44
spinal cord, newborn, donor10223	10359-105E8	42.25	6.89	16.53	1.84	1.38	1.84	1.84	2.76	2.30	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	2.39	3.58	0.75	2.24	1.05	0.90	2.39	1.79	2.54	2.39
spleen, adult, pool1	10025-101D7	15.64	13.11	4.96	7.49	4.19	4.96	5.18	2.53	2.53	6.83
spleen, fetal, pool1	10044-101F8	33.29	17.40	10.33	10.33	6.36	8.90	5.24	5.09	4.53	7.63
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	11.08	0.62	1.76	0.00	0.00	0.93	0.00	2.07	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	3.42	3.80	1.33	0.00	0.00	2.85	0.00	1.33	3.61	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	24.46	5.94	3.84	6.64	8.74	6.99	5.59	2.80	5.59	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.08	1.56	0.78	0.00	0.00	0.39	0.39	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	12.16	12.83	1.35	0.11	0.68	5.18	0.11	3.49	2.70	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	2.12	0.42	0.42	0.42	0.00	1.27	0.00	1.69	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	4.65	1.69	0.00	0.85	0.85	0.42	0.42	0.85	2.54	0.00
stomach, fetal, donor1	10062-101H8	34.18	10.68	2.14	7.48	19.22	5.34	4.27	10.68	16.02	7.48
submaxillary gland, adult	10202-103F4	24.50	10.25	9.11	2.28	5.70	7.41	2.85	2.28	9.68	2.85
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	63.97	4.36	17.66	2.28	3.74	1.66	1.04	6.23	2.08	2.91
substantia nigra, adult, donor10258	10371-105G2	27.93	2.07	16.03	0.52	1.03	1.03	1.03	5.17	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	52.29	7.07	9.89	2.12	4.95	2.12	0.71	7.07	4.24	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	19.95	16.28	1.15	8.48	2.52	7.11	6.65	4.81	1.38	2.98
temporal lobe, adult, pool1	10031-101E4	34.93	6.02	39.59	5.93	9.16	5.00	10.00	4.75	2.12	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	154.56	33.48	27.07	1.42	11.40	19.94	2.14	17.81	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	196.47	13.63	16.26	2.20	8.35	24.61	3.08	16.26	1.76	1.76
tenocyte, donor1	11763-123H8	1.40	0.35	2.79	4.54	1.75	0.35	1.40	0.00	1.05	1.40
tenocyte, donor2	11765-123I1	1.53	0.00	0.38	1.91	1.53	0.76	0.38	0.76	0.38	1.14
tenocyte, donor3	11768-123I4	1.85	0.37	0.74	1.85	0.37	0.00	0.37	0.37	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	40.45	16.49	1.02	5.61	2.04	5.44	1.87	15.30	1.70	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	16.49	12.18	0.62	0.62	2.00	2.31	1.39	4.01	2.00	0.77
teratocarcinoma cell line:PA-1	10807-111A6	10.38	10.38	0.15	1.55	1.86	1.86	1.70	5.11	0.93	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.14	5.59	1.27	3.55	0.63	8.89	3.05	6.98	1.40	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.61	16.64	0.00	2.27	1.13	9.83	1.51	5.67	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	33.05	13.96	2.40	3.16	1.20	7.63	1.31	5.45	2.84	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	17.26	11.40	0.65	19.54	2.28	15.63	9.12	7.17	1.63	0.98
testis, adult, pool1	10026-101D8	26.09	3.65	8.91	11.27	8.16	3.11	5.48	6.01	1.61	5.05
testis, adult, pool2	10096-102C6	88.41	5.86	13.08	7.22	7.22	4.51	2.71	10.83	2.71	4.06
thalamus - adult, donor10196	10168-103B6	50.78	7.73	14.35	0.00	4.42	1.10	4.42	6.62	0.00	1.10
thalamus, adult, donor10252	10154-103A1	97.05	8.28	22.82	4.84	6.41	2.50	4.22	6.41	2.50	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	69.28	1.54	23.09	3.08	1.54	3.08	1.54	3.08	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.41	2.64	10.70	2.31	2.96	1.65	1.65	1.65	1.32	0.16
thalamus, newborn, donor10223	10366-105F6	28.19	2.30	6.90	2.88	3.45	0.58	2.88	2.30	0.00	1.15
throat, adult	10209-103G2	22.47	3.75	10.49	11.73	10.24	3.00	4.74	4.49	5.49	4.49
throat, fetal, donor1	10061-101H7	24.07	8.23	8.53	3.05	8.84	3.66	2.74	6.09	4.27	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	19.08	0.40	3.38	0.79	0.99	2.58	2.98	7.15	0.40	0.60
thymus, adult, pool1	10027-101D9	40.86	5.07	8.55	1.99	2.68	4.08	4.18	2.29	0.99	4.47
thymus, fetal, pool1	10043-101F7	100.68	12.57	13.30	2.70	3.84	6.65	4.99	5.61	1.77	3.95
thyroid carcinoma cell line:KHM-5M	10776-110G2	6.38	3.19	0.93	1.06	0.53	0.66	1.60	0.80	1.20	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	7.12	4.89	3.35	3.07	1.96	1.40	0.56	0.98	2.10	1.26
thyroid, adult, pool1	10028-101E1	20.72	8.30	10.26	13.53	12.32	1.40	9.24	3.73	7.37	4.11
thyroid, fetal, donor1	10060-101H6	50.89	10.81	10.02	4.75	8.17	3.16	2.90	16.08	3.43	2.64
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	15.40	12.32	27.72	6.16	3.08	6.16	9.24	21.56	3.08
tongue, adult	10203-103F5	15.58	3.02	6.28	4.42	9.07	2.33	3.26	1.63	3.02	1.16
tongue, fetal, donor1	10059-101H5	9.06	5.52	4.73	3.94	8.67	1.97	0.79	1.18	0.00	0.79
tonsil, adult, pool1	10047-101G2	28.65	12.22	11.32	3.41	4.21	6.21	7.31	4.01	6.01	6.11
trachea, adult, pool1	10029-101E2	14.97	7.93	5.48	9.82	4.34	2.94	4.58	2.21	8.92	3.52
trachea, fetal, donor1	10058-101H4	17.31	6.16	5.39	6.16	7.69	2.69	4.23	4.62	5.00	6.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	2.48	7.09	2.13	6.02	1.06	1.77	2.13	0.35	2.83	3.54
transitional-cell carcinoma cell line:5637	10418-106C4	6.99	15.91	2.03	1.93	2.13	6.59	2.33	1.52	2.23	2.53
transitional-cell carcinoma cell line:JMSU1	10492-107B6	7.36	6.89	7.21	3.92	2.51	6.42	2.04	3.29	2.51	1.41
tridermal teratoma cell line:HGRT	10694-109G1	5.71	7.61	0.00	3.81	0.00	3.81	1.90	3.81	11.42	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	7.70	15.32	0.76	13.88	2.79	4.06	3.39	2.45	6.77	4.57
umbilical cord, fetal, donor1	10057-101H3	29.21	2.09	6.26	4.17	14.61	4.17	2.09	2.09	4.17	4.17
uterus, adult, pool1	10100-102D1	51.19	17.40	40.78	20.30	12.46	7.17	12.63	4.27	9.56	13.65
uterus, fetal, donor1	10055-101H1	27.13	12.80	7.68	8.19	12.80	4.61	7.17	5.63	6.66	5.63
vagina, adult	10204-103F6	40.71	5.82	8.40	25.20	17.45	1.94	12.92	5.82	7.75	5.17
vein, adult	10191-103E2	23.45	4.82	6.58	9.86	9.21	4.38	3.51	3.51	1.32	7.23
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.81	1.87	0.27	0.80	0.00	0.27	0.80	1.60	1.07	0.80